ONTOLOGY REPORT - ANNOTATIONS
| Term: | butyric acid |
|
| Accession: | CHEBI:30772
|
browse the term
|
| Definition: | A four-carbon straight-chain saturated fatty acid. |
| Synonyms: | related_synonym: | 1-butanoic acid; 1-butyric acid; 1-propanecarboxylic acid; 4:0; BUTANOIC ACID; Butanoic acid; Buttersaeure; C4:0; C4H8O2; CCCC(O)=O; CH3-[CH2]2-COOH; InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6); InChIKey=FERIUCNNQQJTOY-UHFFFAOYSA-N; acide butanoique; acide butyrique; butanic acid; butanoic acid; butoic acid; ethylacetic acid; n-butanoic acid; n-butyric acid; propanecarboxylic acid; propylformic acid |
| | alt_id: | CHEBI:113450; CHEBI:22948; CHEBI:3234; CHEBI:41208 |
| | xref_casrn: | 107-92-6 |
| | xref: | Beilstein:906770 "Beilstein Registry Number"; ChEMBL:10956204 "PubMed citation"; ChEMBL:113450 "ChEMBL COMPOUND"; ChEMBL:1542095 "PubMed citation"; ChemIDplus:107-92-6 "CAS Registry Number"; CiteXplore:10736622 "PubMed citation"; CiteXplore:11201044 "PubMed citation"; CiteXplore:11208715 "PubMed citation"; CiteXplore:11238216 "PubMed citation"; CiteXplore:11305323 "PubMed citation"; CiteXplore:12068484 "PubMed citation"; CiteXplore:13678314 "PubMed citation"; CiteXplore:14962641 "PubMed citation"; CiteXplore:15809727 "PubMed citation"; CiteXplore:15810631 "PubMed citation"; CiteXplore:15938880 "PubMed citation"; CiteXplore:19318247 "PubMed citation"; CiteXplore:19366864 "PubMed citation"; CiteXplore:19703412 "PubMed citation"; CiteXplore:21699495 "PubMed citation"; CiteXplore:22038864 "PubMed citation"; CiteXplore:22194341 "PubMed citation"; CiteXplore:22322557 "PubMed citation"; CiteXplore:22339023 "PubMed citation"; CiteXplore:22466881 "PubMed citation"; DrugBank:DB03568 "DrugBank"; Gmelin:26242 "Gmelin Registry Number"; HMDB:HMDB00039 "HMDB"; KEGG COMPOUND:107-92-6 "CAS Registry Number"; KEGG COMPOUND:C00246 "KEGG COMPOUND"; LIPID MAPS:LMFA01010004 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D020148 |
| | xref: | MetaCyc:BUTYRIC_ACID "MetaCyc"; NIST Chemistry WebBook:107-92-6 "CAS Registry Number"; PDBeChem:BUA "PDBeChem"; Reaxys:906770 "Reaxys Registry Number"; Wikipedia:Butyric_acid "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:17968 |
|
|
butyric acid
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
increases expression |
EXP |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Aimp2 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 |
|
decreases expression |
EXP |
12 |
11,028,968 |
11,038,458 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
B2m |
beta-2 microglobulin |
|
decreases stability |
ISO |
3 |
108,927,919 |
108,932,718 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bin1 |
bridging integrator 1 |
|
increases expression |
EXP |
18 |
24,813,407 |
24,872,852 |
RGD:6480464 |
CTD |
| G |
Bmyc |
brain expressed myelocytomatosis oncogene |
|
increases expression |
EXP |
3 |
3,864,740 |
3,865,499 |
RGD:6480464 |
CTD |
| G |
Btg1 |
B-cell translocation gene 1, anti-proliferative |
|
increases expression |
EXP |
7 |
34,029,300 |
34,031,557 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
increases expression |
EXP |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
decreases expression |
EXP |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
increases expression |
ISO |
8 |
126,492,636 |
126,499,220 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
affects expression |
EXP |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd55 |
Cd55 molecule |
|
increases expression |
EXP |
13 |
43,322,246 |
43,348,334 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cds1 |
CDP-diacylglycerol synthase 1 |
|
increases expression |
EXP |
14 |
9,074,826 |
9,135,391 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
decreases stability |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
increases expression |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
multiple interactions |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
multiple interactions |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
multiple interactions |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
increases expression |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
increases expression |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
multiple interactions |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Clec7a |
C-type lectin domain family 7, member A |
|
increases expression |
ISO |
4 |
166,723,515 |
166,734,681 |
RGD:6480464 |
CTD |
| G |
Cnbp |
CCHC-type zinc finger, nucleic acid binding protein |
|
decreases expression |
EXP |
4 |
122,033,037 |
122,041,891 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
EXP |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddx39a |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A |
|
decreases expression |
EXP |
19 |
26,109,094 |
26,117,042 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
affects expression |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
increases activity |
ISO |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
multiple interactions |
ISO |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
decreases expression |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
|
increases expression |
EXP |
3 |
3,564,380 |
3,569,801 |
RGD:6480464 |
CTD |
| G |
Epx |
eosinophil peroxidase |
|
increases expression |
ISO |
10 |
76,160,005 |
76,171,089 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
decreases expression |
EXP |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fosl2 |
fos-like antigen 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
decreases expression |
EXP |
2 |
46,542,246 |
46,550,678 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
decreases expression |
EXP |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
multiple interactions |
ISO |
X |
26,564,259 |
26,572,081 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
multiple interactions |
ISO |
X |
26,564,259 |
26,572,081 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
increases expression |
ISO |
X |
26,564,259 |
26,572,081 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
multiple interactions |
ISO |
X |
26,564,259 |
26,572,081 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
increases expression |
ISO |
X |
26,564,259 |
26,572,081 |
RGD:6480464 |
CTD |
| G |
Gata2 |
GATA binding protein 2 |
|
multiple interactions |
ISO |
4 |
122,279,753 |
122,288,528 |
RGD:6480464 |
CTD |
| G |
Gata2 |
GATA binding protein 2 |
|
increases expression |
ISO |
4 |
122,279,753 |
122,288,528 |
RGD:6480464 |
CTD |
| G |
Gata2 |
GATA binding protein 2 |
|
multiple interactions |
ISO |
4 |
122,279,753 |
122,288,528 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Grn |
granulin |
|
increases expression |
EXP |
10 |
91,536,135 |
91,542,239 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
decreases expression |
EXP |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Hdac6 |
histone deacetylase 6 |
|
multiple interactions |
ISO |
X |
26,585,852 |
26,606,999 |
RGD:6480464 |
CTD |
| G |
Hist3h3 |
histone cluster 3, H3 |
|
increases acetylation |
ISO |
10 |
45,252,993 |
45,253,403 |
RGD:6480464 |
CTD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
multiple interactions |
ISO |
8 |
47,314,235 |
47,321,604 |
RGD:6480464 |
CTD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
multiple interactions |
ISO |
8 |
47,314,235 |
47,321,604 |
RGD:6480464 |
CTD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
increases expression |
ISO |
8 |
47,314,235 |
47,321,604 |
RGD:6480464 |
CTD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
multiple interactions |
ISO |
8 |
47,314,235 |
47,321,604 |
RGD:6480464 |
CTD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
increases expression |
ISO |
8 |
47,314,235 |
47,321,604 |
RGD:6480464 |
CTD |
| G |
Hnf1a |
HNF1 homeobox A |
|
affects expression |
EXP |
12 |
42,919,574 |
42,945,670 |
RGD:6480464 |
CTD |
| G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
decreases expression |
EXP |
7 |
142,150,229 |
142,154,520 |
RGD:6480464 |
CTD |
| G |
Hnrnpc |
heterogeneous nuclear ribonucleoprotein C (C1/C2) |
|
decreases expression |
EXP |
15 |
27,516,839 |
27,546,646 |
RGD:6480464 |
CTD |
| G |
Hspa13 |
heat shock protein 13 |
|
increases expression |
EXP |
11 |
14,521,734 |
14,535,915 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
decreases expression |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
increases expression |
EXP |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
increases expression |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
EXP |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Kat5 |
K(lysine) acetyltransferase 5 |
|
multiple interactions |
ISO |
1 |
208,233,434 |
208,240,738 |
RGD:6480464 |
CTD |
| G |
Kat5 |
K(lysine) acetyltransferase 5 |
|
increases expression |
ISO |
1 |
208,233,434 |
208,240,738 |
RGD:6480464 |
CTD |
| G |
Kctd13 |
potassium channel tetramerisation domain containing 13 |
|
increases expression |
EXP |
1 |
186,104,306 |
186,122,853 |
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
increases expression |
ISO |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
affects abundance |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lgals9 |
lectin, galactoside-binding, soluble, 9 |
|
increases expression |
EXP |
10 |
65,129,006 |
65,152,052 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
decreases expression |
EXP |
19 |
13,978,940 |
14,000,641 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
increases expression |
EXP |
8 |
4,526,018 |
4,533,730 |
RGD:6480464 |
CTD |
| G |
Mpzl1 |
myelin protein zero-like 1 |
|
increases expression |
EXP |
13 |
81,321,155 |
81,357,929 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Naa15 |
N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
|
decreases expression |
EXP |
2 |
140,308,955 |
140,371,869 |
RGD:6480464 |
CTD |
| G |
Nfe2 |
nuclear factor, erythroid derived 2 |
|
multiple interactions |
ISO |
7 |
142,157,045 |
142,164,122 |
RGD:6480464 |
CTD |
| G |
Nfe2 |
nuclear factor, erythroid derived 2 |
|
increases expression |
ISO |
7 |
142,157,045 |
142,164,122 |
RGD:6480464 |
CTD |
| G |
Nfe2 |
nuclear factor, erythroid derived 2 |
|
multiple interactions |
ISO |
7 |
142,157,045 |
142,164,122 |
RGD:6480464 |
CTD |
| G |
Nfe2 |
nuclear factor, erythroid derived 2 |
|
multiple interactions |
ISO |
7 |
142,157,045 |
142,164,122 |
RGD:6480464 |
CTD |
| G |
Nfe2 |
nuclear factor, erythroid derived 2 |
|
increases expression |
ISO |
7 |
142,157,045 |
142,164,122 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases expression |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Ngfr |
nerve growth factor receptor |
|
increases expression |
EXP |
10 |
84,262,804 |
84,281,006 |
RGD:6480464 |
CTD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
decreases expression |
EXP |
6 |
76,916,943 |
76,920,133 |
RGD:6480464 |
CTD |
| G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
|
decreases expression |
EXP |
1 |
251,297,417 |
251,308,127 |
RGD:6480464 |
CTD |
| G |
Npm1 |
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
decreases expression |
EXP |
10 |
18,051,990 |
18,062,714 |
RGD:6480464 |
CTD |
| G |
Nppb |
natriuretic peptide B |
|
increases expression |
EXP |
5 |
165,062,348 |
165,063,650 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
increases expression |
EXP |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Park7 |
parkinson protein 7 |
|
increases expression |
ISO |
5 |
168,050,149 |
168,061,616 |
RGD:6480464 |
CTD |
| G |
Park7 |
parkinson protein 7 |
|
increases expression |
ISO |
5 |
168,050,149 |
168,061,616 |
RGD:6480464 |
CTD |
| G |
Park7 |
parkinson protein 7 |
|
increases expression |
EXP |
5 |
168,050,149 |
168,061,616 |
RGD:6480464 |
CTD |
| G |
Pip4k2c |
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma |
|
increases expression |
EXP |
7 |
67,151,468 |
67,166,564 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
affects expression |
EXP |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
EXP |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Prg2 |
proteoglycan 2, bone marrow |
|
increases expression |
ISO |
3 |
68,209,731 |
68,213,293 |
RGD:6480464 |
CTD |
| G |
Prkag1 |
protein kinase, AMP-activated, gamma 1 non-catalytic subunit |
|
increases expression |
EXP |
7 |
137,582,341 |
137,599,762 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
increases expression |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
increases expression |
EXP |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Psat1 |
phosphoserine aminotransferase 1 |
|
decreases expression |
EXP |
1 |
219,268,419 |
219,290,273 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
increases expression |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pura |
purine rich element binding protein A |
|
increases expression |
EXP |
18 |
28,916,722 |
28,925,008 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine-rich |
|
decreases expression |
EXP |
5 |
146,460,306 |
146,469,289 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects activity |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases activity |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Srpk1 |
SRSF protein kinase 1 |
|
affects localization |
ISO |
20 |
6,829,410 |
6,870,877 |
RGD:6480464 |
CTD |
| G |
Srpk2 |
SRSF protein kinase 2 |
|
affects localization |
ISO |
4 |
6,918,521 |
7,039,871 |
RGD:6480464 |
CTD |
| G |
Srsf2 |
serine/arginine-rich splicing factor 2 |
|
multiple interactions |
ISO |
10 |
106,954,365 |
106,956,807 |
RGD:6480464 |
CTD |
| G |
Srsf2 |
serine/arginine-rich splicing factor 2 |
|
decreases phosphorylation |
ISO |
10 |
106,954,365 |
106,956,807 |
RGD:6480464 |
CTD |
| G |
Srsf2 |
serine/arginine-rich splicing factor 2 |
|
increases expression |
ISO |
10 |
106,954,365 |
106,956,807 |
RGD:6480464 |
CTD |
| G |
Stxbp1 |
syntaxin binding protein 1 |
|
increases expression |
EXP |
3 |
11,762,105 |
11,825,531 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
decreases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
increases expression |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tlr1 |
toll-like receptor 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tlr6 |
toll-like receptor 6 |
|
increases expression |
ISO |
14 |
46,089,365 |
46,100,687 |
RGD:6480464 |
CTD |
| G |
Tmem205 |
transmembrane protein 205 |
|
increases expression |
EXP |
8 |
21,024,232 |
21,029,968 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
EXP |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Ube2b |
ubiquitin-conjugating enzyme E2B |
|
increases expression |
EXP |
10 |
37,509,322 |
37,523,900 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
affects expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
3-methyl-2-oxobutanoic acid
|
| G |
Lepr |
leptin receptor |
|
affects abundance |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
affects abundance |
ISO |
|
|
|
RGD:6480464 |
CTD |
L-methionine
|
| G |
Aard |
alanine and arginine rich domain containing protein |
|
multiple interactions |
ISO |
7 |
88,346,189 |
88,351,030 |
RGD:6480464 |
CTD |
| G |
Abat |
4-aminobutyrate aminotransferase |
|
multiple interactions |
ISO |
10 |
7,040,725 |
7,137,154 |
RGD:6480464 |
CTD |
| G |
Abca5 |
ATP-binding cassette, subfamily A (ABC1), member 5 |
|
multiple interactions |
ISO |
10 |
99,724,778 |
99,793,593 |
RGD:6480464 |
CTD |
| G |
Abca8a |
ATP-binding cassette, subfamily A (ABC1), member 8a |
|
multiple interactions |
ISO |
10 |
99,477,700 |
99,544,364 |
RGD:6480464 |
CTD |
| G |
Abcb10 |
ATP-binding cassette, subfamily B (MDR/TAP), member 10 |
|
multiple interactions |
ISO |
19 |
54,151,400 |
54,181,495 |
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
multiple interactions |
ISO |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
multiple interactions |
EXP |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
multiple interactions |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
EXP |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
multiple interactions |
ISO |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
EXP |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abhd11 |
abhydrolase domain containing 11 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abhd12 |
abhydrolase domain containing 12 |
|
multiple interactions |
ISO |
3 |
141,468,888 |
141,530,219 |
RGD:6480464 |
CTD |
| G |
Abhd2 |
abhydrolase domain containing 2 |
|
multiple interactions |
ISO |
1 |
135,025,144 |
135,111,792 |
RGD:6480464 |
CTD |
| G |
Ablim3 |
actin binding LIM protein family, member 3 |
|
multiple interactions |
ISO |
18 |
57,781,588 |
57,900,968 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
multiple interactions |
ISO |
4 |
76,957,477 |
76,977,643 |
RGD:6480464 |
CTD |
| G |
Abr |
active BCR-related |
|
multiple interactions |
ISO |
10 |
67,617,776 |
67,760,961 |
RGD:6480464 |
CTD |
| G |
Abtb1 |
ankyrin repeat and BTB (POZ) domain containing 1 |
|
multiple interactions |
ISO |
4 |
122,930,404 |
122,936,631 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
multiple interactions |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
|
multiple interactions |
ISO |
2 |
122,562,974 |
122,585,953 |
RGD:6480464 |
CTD |
| G |
Acbd5 |
acyl-CoA binding domain containing 5 |
|
multiple interactions |
ISO |
17 |
96,677,365 |
96,716,091 |
RGD:6480464 |
CTD |
| G |
Acbd6 |
acyl-CoA binding domain containing 6 |
|
multiple interactions |
ISO |
13 |
70,519,376 |
70,654,968 |
RGD:6480464 |
CTD |
| G |
Acer2 |
alkaline ceramidase 2 |
|
multiple interactions |
ISO |
5 |
106,185,779 |
106,237,588 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
multiple interactions |
ISO |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
multiple interactions |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Acot2 |
acyl-CoA thioesterase 2 |
|
multiple interactions |
ISO |
6 |
108,017,574 |
108,024,387 |
RGD:6480464 |
CTD |
| G |
Acot5 |
acyl-CoA thioesterase 5 |
|
multiple interactions |
ISO |
6 |
108,114,686 |
108,122,769 |
RGD:6480464 |
CTD |
| G |
Acot9 |
acyl-CoA thioesterase 9 |
|
multiple interactions |
ISO |
X |
61,548,318 |
61,600,120 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
multiple interactions |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
multiple interactions |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
multiple interactions |
ISO |
X |
36,168,547 |
36,232,162 |
RGD:6480464 |
CTD |
| G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
|
multiple interactions |
ISO |
3 |
141,259,016 |
141,308,871 |
RGD:6480464 |
CTD |
| G |
Acta1 |
actin, alpha 1, skeletal muscle |
|
multiple interactions |
ISO |
19 |
54,081,496 |
54,084,508 |
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
multiple interactions |
ISO |
3 |
99,901,022 |
99,906,558 |
RGD:6480464 |
CTD |
| G |
Actr1a |
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) |
|
multiple interactions |
ISO |
1 |
251,592,429 |
251,611,097 |
RGD:6480464 |
CTD |
| G |
Actr5 |
ARP5 actin-related protein 5 homolog (yeast) |
|
multiple interactions |
ISO |
3 |
149,357,984 |
149,371,469 |
RGD:6480464 |
CTD |
| G |
Acvr1c |
activin A receptor, type IC |
|
multiple interactions |
ISO |
3 |
40,027,228 |
40,102,303 |
RGD:6480464 |
CTD |
| G |
Acvr2b |
activin A receptor, type IIB |
|
multiple interactions |
ISO |
8 |
124,364,330 |
124,395,748 |
RGD:6480464 |
CTD |
| G |
Adam11 |
ADAM metallopeptidase domain 11 |
|
multiple interactions |
ISO |
10 |
91,881,174 |
91,896,961 |
RGD:6480464 |
CTD |
| G |
Adam12 |
ADAM metallopeptidase domain 12 |
|
multiple interactions |
ISO |
1 |
193,384,457 |
193,650,892 |
RGD:6480464 |
CTD |
| G |
Adam15 |
ADAM metallopeptidase domain 15 |
|
multiple interactions |
ISO |
2 |
181,527,175 |
181,537,640 |
RGD:6480464 |
CTD |
| G |
Adam19 |
ADAM metallopeptidase domain 19 |
|
multiple interactions |
ISO |
10 |
31,190,242 |
31,282,773 |
RGD:6480464 |
CTD |
| G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
multiple interactions |
ISO |
1 |
199,780,772 |
199,791,855 |
RGD:6480464 |
CTD |
| G |
Adamts15 |
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
|
multiple interactions |
ISO |
8 |
30,683,281 |
30,706,659 |
RGD:6480464 |
CTD |
| G |
Adamts16 |
ADAM metallopeptidase with thrombospondin type 1 motif, 16 |
|
multiple interactions |
ISO |
17 |
2,559,771 |
2,690,663 |
RGD:6480464 |
CTD |
| G |
Adamts2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
|
multiple interactions |
ISO |
10 |
36,168,655 |
36,377,640 |
RGD:6480464 |
CTD |
| G |
Adamts7 |
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
|
multiple interactions |
ISO |
8 |
95,068,562 |
95,108,273 |
RGD:6480464 |
CTD |
| G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
multiple interactions |
ISO |
4 |
126,996,604 |
127,198,909 |
RGD:6480464 |
CTD |
| G |
Adamtsl2 |
ADAMTS-like 2 |
|
multiple interactions |
ISO |
3 |
5,976,490 |
6,004,532 |
RGD:6480464 |
CTD |
| G |
Adamtsl5 |
ADAMTS-like 5 |
|
multiple interactions |
ISO |
7 |
10,874,586 |
10,879,783 |
RGD:6480464 |
CTD |
| G |
Adap2 |
ArfGAP with dual PH domains 2 |
|
multiple interactions |
ISO |
10 |
68,360,450 |
68,390,279 |
RGD:6480464 |
CTD |
| G |
Adc |
arginine decarboxylase |
|
multiple interactions |
ISO |
5 |
148,100,546 |
148,110,453 |
RGD:6480464 |
CTD |
| G |
Adcy2 |
adenylate cyclase 2 (brain) |
|
multiple interactions |
ISO |
17 |
4,543,466 |
5,040,433 |
RGD:6480464 |
CTD |
| G |
Adcy3 |
adenylate cyclase 3 |
|
multiple interactions |
ISO |
6 |
27,118,325 |
27,202,275 |
RGD:6480464 |
CTD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
multiple interactions |
ISO |
19 |
20,051,639 |
20,073,861 |
RGD:6480464 |
CTD |
| G |
Add3 |
adducin 3 (gamma) |
|
multiple interactions |
ISO |
1 |
259,347,673 |
259,455,407 |
RGD:6480464 |
CTD |
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
multiple interactions |
ISO |
2 |
235,979,108 |
235,991,515 |
RGD:6480464 |
CTD |
| G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
|
multiple interactions |
ISO |
2 |
235,749,346 |
235,765,063 |
RGD:6480464 |
CTD |
| G |
Adhfe1 |
alcohol dehydrogenase, iron containing, 1 |
|
multiple interactions |
ISO |
5 |
9,276,929 |
9,303,483 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
multiple interactions |
ISO |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adnp2 |
ADNP homeobox 2 |
|
multiple interactions |
ISO |
18 |
77,017,502 |
77,041,570 |
RGD:6480464 |
CTD |
| G |
Adora2b |
adenosine A2B receptor |
|
multiple interactions |
ISO |
10 |
48,421,592 |
48,437,967 |
RGD:6480464 |
CTD |
| G |
Adprh |
ADP-ribosylarginine hydrolase |
|
multiple interactions |
ISO |
11 |
64,079,175 |
64,085,514 |
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
multiple interactions |
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adssl1 |
adenylosuccinate synthase like 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Aen |
apoptosis enhancing nuclease |
|
multiple interactions |
ISO |
1 |
134,615,998 |
134,625,367 |
RGD:6480464 |
CTD |
| G |
Afg3l1 |
AFG3(ATPase family gene 3)-like 1 (S. cerevisiae) |
|
multiple interactions |
ISO |
19 |
53,794,261 |
53,821,667 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
multiple interactions |
ISO |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
|
multiple interactions |
ISO |
7 |
67,031,300 |
67,043,909 |
RGD:6480464 |
CTD |
| G |
Agpat4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
|
multiple interactions |
ISO |
1 |
42,986,809 |
43,096,390 |
RGD:6480464 |
CTD |
| G |
Agtpbp1 |
ATP/GTP binding protein 1 |
|
multiple interactions |
ISO |
17 |
11,040,339 |
11,155,923 |
RGD:6480464 |
CTD |
| G |
Ahcy |
adenosylhomocysteinase |
|
multiple interactions |
ISO |
3 |
145,544,834 |
145,560,058 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein |
|
multiple interactions |
ISO |
1 |
211,662,523 |
211,692,558 |
RGD:6480464 |
CTD |
| G |
Ahrr |
aryl-hydrocarbon receptor repressor |
|
multiple interactions |
ISO |
1 |
29,797,025 |
29,894,912 |
RGD:6480464 |
CTD |
| G |
Aig1 |
androgen-induced 1 |
|
multiple interactions |
ISO |
1 |
8,456,587 |
8,688,694 |
RGD:6480464 |
CTD |
| G |
Ak1 |
adenylate kinase 1 |
|
multiple interactions |
ISO |
2 |
19,821,482 |
19,822,544 |
RGD:6480464 |
CTD |
| G |
Ak2 |
adenylate kinase 2 |
|
multiple interactions |
ISO |
5 |
148,156,751 |
148,176,195 |
RGD:6480464 |
CTD |
| G |
Ak7 |
adenylate kinase 7 |
|
multiple interactions |
ISO |
6 |
129,861,499 |
129,933,903 |
RGD:6480464 |
CTD |
| G |
Akap1 |
A kinase (PRKA) anchor protein 1 |
|
multiple interactions |
ISO |
10 |
77,262,592 |
77,276,832 |
RGD:6480464 |
CTD |
| G |
Akap5 |
A kinase (PRKA) anchor protein 5 |
|
multiple interactions |
ISO |
6 |
98,923,105 |
98,928,505 |
RGD:6480464 |
CTD |
| G |
Akna |
AT-hook transcription factor |
|
multiple interactions |
ISO |
5 |
80,329,462 |
80,368,061 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
multiple interactions |
ISO |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
|
multiple interactions |
ISO |
4 |
61,794,352 |
61,806,916 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
multiple interactions |
ISO |
4 |
61,714,282 |
61,726,856 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
multiple interactions |
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aktip |
AKT interacting protein |
|
multiple interactions |
ISO |
19 |
17,035,220 |
17,045,096 |
RGD:6480464 |
CTD |
| G |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
|
multiple interactions |
ISO |
1 |
245,685,979 |
245,718,198 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
multiple interactions |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
|
multiple interactions |
ISO |
7 |
22,398,067 |
22,450,381 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh3b1 |
aldehyde dehydrogenase 3 family, member B1 |
|
multiple interactions |
ISO |
1 |
206,438,325 |
206,455,477 |
RGD:6480464 |
CTD |
| G |
Aldh3b2 |
aldehyde dehydrogenase 3 family, member B2 |
|
multiple interactions |
ISO |
1 |
206,549,529 |
206,553,424 |
RGD:6480464 |
CTD |
| G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
|
multiple interactions |
ISO |
5 |
158,437,691 |
158,453,827 |
RGD:6480464 |
CTD |
| G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
|
multiple interactions |
ISO |
18 |
52,300,899 |
52,333,149 |
RGD:6480464 |
CTD |
| G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
|
multiple interactions |
ISO |
13 |
83,017,312 |
83,034,047 |
RGD:6480464 |
CTD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
multiple interactions |
ISO |
6 |
23,009,061 |
23,730,939 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
multiple interactions |
ISO |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Alx3 |
ALX homeobox 3 |
|
multiple interactions |
ISO |
2 |
203,156,009 |
203,157,503 |
RGD:6480464 |
CTD |
| G |
Amn |
amnion associated transmembrane protein |
|
multiple interactions |
ISO |
6 |
136,031,478 |
136,038,919 |
RGD:6480464 |
CTD |
| G |
Amotl1 |
angiomotin-like 1 |
|
multiple interactions |
ISO |
8 |
11,296,503 |
11,392,970 |
RGD:6480464 |
CTD |
| G |
Anapc5 |
anaphase-promoting complex subunit 5 |
|
multiple interactions |
ISO |
12 |
34,850,485 |
34,884,726 |
RGD:6480464 |
CTD |
| G |
Angptl6 |
angiopoietin-like 6 |
|
multiple interactions |
ISO |
8 |
19,899,121 |
19,905,696 |
RGD:6480464 |
CTD |
| G |
Ank2 |
ankyrin 2, neuronal |
|
multiple interactions |
ISO |
2 |
224,182,431 |
224,501,751 |
RGD:6480464 |
CTD |
| G |
Ankhd1 |
ankyrin repeat and KH domain containing 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ankle1 |
ankyrin repeat and LEM domain containing 1 |
|
multiple interactions |
ISO |
16 |
18,565,676 |
18,569,219 |
RGD:6480464 |
CTD |
| G |
Ankrd1 |
ankyrin repeat domain 1 |
|
multiple interactions |
ISO |
1 |
240,316,123 |
240,324,804 |
RGD:6480464 |
CTD |
| G |
Ankrd12 |
ankyrin repeat domain 12 |
|
multiple interactions |
ISO |
9 |
104,746,476 |
104,823,263 |
RGD:6480464 |
CTD |
| G |
Ankrd13b |
ankyrin repeat domain 13B |
|
multiple interactions |
ISO |
10 |
66,628,069 |
66,646,674 |
RGD:6480464 |
CTD |
| G |
Ankrd16 |
ankyrin repeat domain 16 |
|
multiple interactions |
ISO |
17 |
77,930,658 |
77,943,867 |
RGD:6480464 |
CTD |
| G |
Ankrd27 |
ankyrin repeat domain 27 (VPS9 domain) |
|
multiple interactions |
ISO |
1 |
88,117,683 |
88,139,762 |
RGD:6480464 |
CTD |
| G |
Ankrd34a |
ankyrin repeat domain 34A |
|
multiple interactions |
ISO |
2 |
191,395,509 |
191,398,939 |
RGD:6480464 |
CTD |
| G |
Ankrd34b |
ankyrin repeat domain 34B |
|
multiple interactions |
ISO |
2 |
22,663,047 |
22,678,969 |
RGD:6480464 |
CTD |
| G |
Anks3 |
ankyrin repeat and sterile alpha motif domain containing 3 |
|
multiple interactions |
ISO |
10 |
10,732,109 |
10,752,778 |
RGD:6480464 |
CTD |
| G |
Anks6 |
ankyrin repeat and sterile alpha motif domain containing 6 |
|
multiple interactions |
ISO |
5 |
63,633,540 |
63,674,953 |
RGD:6480464 |
CTD |
| G |
Ano1 |
anoctamin 1, calcium activated chloride channel |
|
multiple interactions |
ISO |
1 |
205,018,529 |
205,166,049 |
RGD:6480464 |
CTD |
| G |
Ano10 |
anoctamin 10 |
|
multiple interactions |
ISO |
8 |
121,978,317 |
122,095,649 |
RGD:6480464 |
CTD |
| G |
Ano2 |
anoctamin 2 |
|
multiple interactions |
ISO |
4 |
161,859,827 |
162,057,876 |
RGD:6480464 |
CTD |
| G |
Ano6 |
anoctamin 6 |
|
multiple interactions |
ISO |
7 |
134,434,775 |
134,624,126 |
RGD:6480464 |
CTD |
| G |
Ano7 |
anoctamin 7 |
|
multiple interactions |
ISO |
9 |
92,655,567 |
92,683,022 |
RGD:6480464 |
CTD |
| G |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
|
multiple interactions |
ISO |
5 |
63,044,718 |
63,058,038 |
RGD:6480464 |
CTD |
| G |
Antxr1 |
anthrax toxin receptor 1 |
|
multiple interactions |
ISO |
4 |
121,297,955 |
121,483,876 |
RGD:6480464 |
CTD |
| G |
Antxr2 |
anthrax toxin receptor 2 |
|
multiple interactions |
ISO |
14 |
12,875,632 |
13,107,975 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
multiple interactions |
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Anxa11 |
annexin A11 |
|
multiple interactions |
ISO |
16 |
1,449,907 |
1,496,053 |
RGD:6480464 |
CTD |
| G |
Anxa13 |
annexin A13 |
|
multiple interactions |
ISO |
7 |
95,071,045 |
95,123,201 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
multiple interactions |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
multiple interactions |
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Aoah |
acyloxyacyl hydrolase (neutrophil) |
|
multiple interactions |
ISO |
17 |
51,475,254 |
51,722,447 |
RGD:6480464 |
CTD |
| G |
Ap1g1 |
adaptor-related protein complex 1, gamma 1 subunit |
|
multiple interactions |
ISO |
19 |
39,676,021 |
39,734,854 |
RGD:6480464 |
CTD |
| G |
Ap1m2 |
adaptor-related protein complex 1, mu 2 subunit |
|
multiple interactions |
ISO |
8 |
20,385,982 |
20,396,146 |
RGD:6480464 |
CTD |
| G |
Ap1s2 |
adaptor-related protein complex 1, sigma 2 subunit |
|
multiple interactions |
ISO |
X |
51,329,574 |
51,356,406 |
RGD:6480464 |
CTD |
| G |
Ap3b1 |
adaptor-related protein complex 3, beta 1 subunit |
|
multiple interactions |
ISO |
2 |
24,670,078 |
24,872,770 |
RGD:6480464 |
CTD |
| G |
Ap3m2 |
adaptor-related protein complex 3, mu 2 subunit |
|
multiple interactions |
ISO |
16 |
73,687,443 |
73,704,278 |
RGD:6480464 |
CTD |
| G |
Ap4e1 |
adaptor-related protein complex 4, epsilon 1 subunit |
|
multiple interactions |
ISO |
3 |
114,550,205 |
114,615,150 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
multiple interactions |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apbb1ip |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
|
multiple interactions |
ISO |
17 |
96,476,962 |
96,527,635 |
RGD:6480464 |
CTD |
| G |
Apcdd1 |
adenomatosis polyposis coli down-regulated 1 |
|
multiple interactions |
ISO |
18 |
59,088,709 |
59,091,205 |
RGD:6480464 |
CTD |
| G |
Apcs |
amyloid P component, serum |
|
multiple interactions |
ISO |
13 |
89,112,845 |
89,113,641 |
RGD:6480464 |
CTD |
| G |
Aph1a |
anterior pharynx defective 1 homolog A (C. elegans) |
|
multiple interactions |
ISO |
2 |
190,679,692 |
190,683,202 |
RGD:6480464 |
CTD |
| G |
Aph1b |
anterior pharynx defective 1 homolog B (C. elegans) |
|
multiple interactions |
ISO |
8 |
71,122,681 |
71,143,726 |
RGD:6480464 |
CTD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
multiple interactions |
ISO |
8 |
49,233,142 |
49,233,431 |
RGD:6480464 |
CTD |
| G |
Apobr |
apolipoprotein B receptor |
|
multiple interactions |
ISO |
1 |
185,726,047 |
185,730,550 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Appl2 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
|
multiple interactions |
ISO |
7 |
22,279,273 |
22,328,427 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
multiple interactions |
ISO |
5 |
58,501,642 |
58,507,159 |
RGD:6480464 |
CTD |
| G |
Aqp4 |
aquaporin 4 |
|
multiple interactions |
ISO |
18 |
6,626,313 |
6,642,766 |
RGD:6480464 |
CTD |
| G |
Aqp5 |
aquaporin 5 |
|
multiple interactions |
ISO |
7 |
138,337,725 |
138,341,257 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
multiple interactions |
ISO |
5 |
58,433,731 |
58,447,853 |
RGD:6480464 |
CTD |
| G |
Aqp9 |
aquaporin 9 |
|
multiple interactions |
ISO |
8 |
75,611,485 |
75,651,646 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arc |
activity-regulated cytoskeleton-associated protein |
|
multiple interactions |
ISO |
7 |
112,771,937 |
112,775,381 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
multiple interactions |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Arf1 |
ADP-ribosylation factor 1 |
|
multiple interactions |
ISO |
10 |
45,516,609 |
45,532,091 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
multiple interactions |
ISO |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arhgap10 |
Rho GTPase activating protein 10 |
|
multiple interactions |
ISO |
19 |
32,261,771 |
32,521,913 |
RGD:6480464 |
CTD |
| G |
Arhgap15 |
Rho GTPase activating protein 15 |
|
multiple interactions |
ISO |
3 |
24,256,620 |
24,389,618 |
RGD:6480464 |
CTD |
| G |
Arhgap22 |
Rho GTPase activating protein 22 |
|
multiple interactions |
ISO |
16 |
8,863,537 |
8,913,459 |
RGD:6480464 |
CTD |
| G |
Arhgap25 |
Rho GTPase activating protein 25 |
|
multiple interactions |
ISO |
4 |
121,620,926 |
121,700,835 |
RGD:6480464 |
CTD |
| G |
Arhgap26 |
Rho GTPase activating protein 26 |
|
multiple interactions |
ISO |
18 |
31,934,753 |
32,327,551 |
RGD:6480464 |
CTD |
| G |
Arhgap30 |
Rho GTPase activating protein 30 |
|
multiple interactions |
ISO |
13 |
87,295,074 |
87,335,018 |
RGD:6480464 |
CTD |
| G |
Arhgap31 |
Rho GTPase activating protein 31 |
|
multiple interactions |
ISO |
11 |
63,814,916 |
63,929,011 |
RGD:6480464 |
CTD |
| G |
Arhgap9 |
Rho GTPase activating protein 9 |
|
multiple interactions |
ISO |
7 |
67,280,267 |
67,288,390 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
multiple interactions |
ISO |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
multiple interactions |
ISO |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Arhgef2 |
rho/rac guanine nucleotide exchange factor (GEF) 2 |
|
multiple interactions |
ISO |
2 |
180,748,313 |
180,775,656 |
RGD:6480464 |
CTD |
| G |
Arhgef6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
|
multiple interactions |
ISO |
X |
141,946,362 |
142,068,557 |
RGD:6480464 |
CTD |
| G |
Arhgef7 |
Rho guanine nucleotide exchange factor (GEF) 7 |
|
multiple interactions |
ISO |
16 |
82,521,224 |
82,603,338 |
RGD:6480464 |
CTD |
| G |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
|
multiple interactions |
ISO |
5 |
151,355,617 |
151,398,647 |
RGD:6480464 |
CTD |
| G |
Arid1b |
AT rich interactive domain 1B (Swi1 like) |
|
multiple interactions |
ISO |
1 |
40,012,872 |
40,324,266 |
RGD:6480464 |
CTD |
| G |
Arid3a |
AT rich interactive domain 3A (Bright like) |
|
multiple interactions |
ISO |
7 |
11,269,055 |
11,290,551 |
RGD:6480464 |
CTD |
| G |
Arid4a |
AT rich interactive domain 4A (Rbp1 like) |
|
multiple interactions |
ISO |
6 |
93,130,856 |
93,201,927 |
RGD:6480464 |
CTD |
| G |
Arl10 |
ADP-ribosylation factor-like 10 |
|
multiple interactions |
ISO |
17 |
16,094,098 |
16,100,342 |
RGD:6480464 |
CTD |
| G |
Arl11 |
ADP-ribosylation factor-like 11 |
|
multiple interactions |
ISO |
15 |
40,458,780 |
40,460,926 |
RGD:6480464 |
CTD |
| G |
Arl2 |
ADP-ribosylation factor-like 2 |
|
multiple interactions |
ISO |
1 |
208,909,458 |
208,921,401 |
RGD:6480464 |
CTD |
| G |
Arl4a |
ADP-ribosylation factor-like 4A |
|
multiple interactions |
ISO |
6 |
59,212,599 |
59,214,609 |
RGD:6480464 |
CTD |
| G |
Arl5c |
ADP-ribosylation factor-like 5C |
|
multiple interactions |
ISO |
10 |
86,751,321 |
86,758,083 |
RGD:6480464 |
CTD |
| G |
Arl6ip4 |
ADP-ribosylation-like factor 6 interacting protein 4 |
|
multiple interactions |
ISO |
12 |
33,603,784 |
33,605,929 |
RGD:6480464 |
CTD |
| G |
Arl8a |
ADP-ribosylation factor-like 8A |
|
multiple interactions |
ISO |
13 |
48,108,242 |
48,117,244 |
RGD:6480464 |
CTD |
| G |
Armc1 |
armadillo repeat containing 1 |
|
multiple interactions |
ISO |
2 |
104,228,985 |
104,273,611 |
RGD:6480464 |
CTD |
| G |
Armcx3 |
armadillo repeat containing, X-linked 3 |
|
multiple interactions |
ISO |
X |
122,217,524 |
122,221,077 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
multiple interactions |
ISO |
1 |
140,535,823 |
140,646,838 |
RGD:6480464 |
CTD |
| G |
Arpc5l |
actin related protein 2/3 complex, subunit 5-like |
|
multiple interactions |
ISO |
3 |
18,798,930 |
18,801,987 |
RGD:6480464 |
CTD |
| G |
Arsg |
arylsulfatase G |
|
multiple interactions |
ISO |
10 |
98,754,633 |
98,833,808 |
RGD:6480464 |
CTD |
| G |
Art4 |
ADP-ribosyltransferase 4 (Dombrock blood group) |
|
multiple interactions |
ISO |
4 |
173,884,317 |
173,893,756 |
RGD:6480464 |
CTD |
| G |
Arvcf |
armadillo repeat gene deleted in velo-cardio-facial syndrome |
|
multiple interactions |
ISO |
11 |
84,582,208 |
84,639,874 |
RGD:6480464 |
CTD |
| G |
Asah2 |
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 |
|
multiple interactions |
ISO |
1 |
236,000,768 |
236,072,477 |
RGD:6480464 |
CTD |
| G |
Asb11 |
ankyrin repeat and SOCS box-containing 11 |
|
multiple interactions |
ISO |
X |
50,771,241 |
50,793,101 |
RGD:6480464 |
CTD |
| G |
Asb13 |
ankyrin repeat and SOCS box-containing 13 |
|
multiple interactions |
ISO |
17 |
77,759,058 |
77,777,760 |
RGD:6480464 |
CTD |
| G |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
|
multiple interactions |
ISO |
9 |
89,056,520 |
89,122,413 |
RGD:6480464 |
CTD |
| G |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
|
multiple interactions |
ISO |
4 |
30,150,502 |
30,188,132 |
RGD:6480464 |
CTD |
| G |
Ash2l |
ash2 (absent, small, or homeotic)-like (Drosophila) |
|
multiple interactions |
ISO |
16 |
70,617,717 |
70,639,166 |
RGD:6480464 |
CTD |
| G |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
|
multiple interactions |
ISO |
10 |
69,103,244 |
70,190,305 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
multiple interactions |
ISO |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Asph |
aspartate-beta-hydroxylase |
|
multiple interactions |
ISO |
5 |
23,495,780 |
23,520,672 |
RGD:6480464 |
CTD |
| G |
Asrgl1 |
asparaginase like 1 |
|
multiple interactions |
ISO |
1 |
211,788,145 |
211,808,943 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
multiple interactions |
ISO |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Asxl1 |
additional sex combs like 1 |
|
multiple interactions |
ISO |
3 |
143,703,295 |
143,767,523 |
RGD:6480464 |
CTD |
| G |
Asxl2 |
additional sex combs like 2 (Drosophila) |
|
multiple interactions |
ISO |
6 |
26,400,855 |
26,482,465 |
RGD:6480464 |
CTD |
| G |
Ate1 |
arginyltransferase 1 |
|
multiple interactions |
ISO |
1 |
189,718,854 |
189,835,976 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
multiple interactions |
ISO |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf5 |
activating transcription factor 5 |
|
multiple interactions |
ISO |
1 |
95,284,505 |
95,286,786 |
RGD:6480464 |
CTD |
| G |
Atf6b |
activating transcription factor 6 beta |
|
multiple interactions |
ISO |
20 |
4,192,185 |
4,200,036 |
RGD:6480464 |
CTD |
| G |
Atg3 |
autophagy related 3 |
|
multiple interactions |
ISO |
11 |
57,162,205 |
57,190,568 |
RGD:6480464 |
CTD |
| G |
Atn1 |
atrophin 1 |
|
multiple interactions |
ISO |
4 |
160,872,360 |
160,886,205 |
RGD:6480464 |
CTD |
| G |
Atp10a |
ATPase, class V, type 10A |
|
multiple interactions |
ISO |
1 |
110,175,554 |
110,360,215 |
RGD:6480464 |
CTD |
| G |
Atp11b |
ATPase, class VI, type 11B |
|
multiple interactions |
ISO |
2 |
122,139,635 |
122,306,306 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
multiple interactions |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
multiple interactions |
ISO |
1 |
80,280,714 |
80,309,834 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
multiple interactions |
ISO |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
|
multiple interactions |
ISO |
4 |
149,655,651 |
149,907,813 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
multiple interactions |
ISO |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Atp5d |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
|
multiple interactions |
ISO |
7 |
11,072,820 |
11,075,906 |
RGD:6480464 |
CTD |
| G |
Atp6v0a1 |
ATPase, H+ transporting, lysosomal V0 subunit A1 |
|
multiple interactions |
ISO |
10 |
89,948,286 |
90,072,304 |
RGD:6480464 |
CTD |
| G |
Atp6v0c |
ATPase, H+ transporting, lysosomal V0 subunit C |
|
multiple interactions |
ISO |
10 |
13,415,671 |
13,420,715 |
RGD:6480464 |
CTD |
| G |
Atp6v0d2 |
ATPase, H+ transporting, lysosomal V0 subunit D2 |
|
multiple interactions |
ISO |
5 |
34,476,045 |
34,524,995 |
RGD:6480464 |
CTD |
| G |
Atp6v0e2 |
ATPase, H+ transporting V0 subunit e2 |
|
multiple interactions |
ISO |
4 |
76,621,828 |
76,624,976 |
RGD:6480464 |
CTD |
| G |
Atp6v1c2 |
ATPase, H+ transporting, lysosomal V1 subunit C2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp8b1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
multiple interactions |
ISO |
18 |
60,748,738 |
60,829,650 |
RGD:6480464 |
CTD |
| G |
Atpif1 |
ATPase inhibitory factor 1 |
|
multiple interactions |
ISO |
5 |
152,618,307 |
152,622,024 |
RGD:6480464 |
CTD |
| G |
Atrnl1 |
attractin like 1 |
|
multiple interactions |
ISO |
1 |
263,919,358 |
264,486,579 |
RGD:6480464 |
CTD |
| G |
Atxn7l2 |
ataxin 7-like 2 |
|
multiple interactions |
ISO |
2 |
203,767,580 |
203,776,399 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
multiple interactions |
ISO |
10 |
55,798,710 |
55,804,367 |
RGD:6480464 |
CTD |
| G |
Avpi1 |
arginine vasopressin-induced 1 |
|
multiple interactions |
ISO |
1 |
248,727,385 |
248,733,112 |
RGD:6480464 |
CTD |
| G |
Axin2 |
axin 2 |
|
multiple interactions |
ISO |
10 |
98,294,466 |
98,321,830 |
RGD:6480464 |
CTD |
| G |
Azin1 |
antizyme inhibitor 1 |
|
multiple interactions |
ISO |
7 |
74,159,130 |
74,189,447 |
RGD:6480464 |
CTD |
| G |
B3galnt1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
|
multiple interactions |
ISO |
2 |
159,670,705 |
159,701,464 |
RGD:6480464 |
CTD |
| G |
B3galt4 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 |
|
multiple interactions |
ISO |
20 |
5,087,855 |
5,089,430 |
RGD:6480464 |
CTD |
| G |
B3galt6 |
UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6 |
|
multiple interactions |
ISO |
5 |
172,833,647 |
172,835,783 |
RGD:6480464 |
CTD |
| G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
|
multiple interactions |
ISO |
14 |
103,499,471 |
103,524,296 |
RGD:6480464 |
CTD |
| G |
B3gnt8 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
|
multiple interactions |
ISO |
1 |
80,834,562 |
80,837,461 |
RGD:6480464 |
CTD |
| G |
B4galnt1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
|
multiple interactions |
ISO |
7 |
67,120,782 |
67,127,697 |
RGD:6480464 |
CTD |
| G |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
|
multiple interactions |
ISO |
1 |
201,260,278 |
201,271,175 |
RGD:6480464 |
CTD |
| G |
B4galt2 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 |
|
multiple interactions |
ISO |
5 |
138,338,706 |
138,347,177 |
RGD:6480464 |
CTD |
| G |
B4galt6 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 |
|
multiple interactions |
ISO |
18 |
12,421,062 |
12,478,276 |
RGD:6480464 |
CTD |
| G |
B9d1 |
B9 protein domain 1 |
|
multiple interactions |
ISO |
10 |
47,665,630 |
47,673,227 |
RGD:6480464 |
CTD |
| G |
Bace1 |
beta-site APP cleaving enzyme 1 |
|
multiple interactions |
ISO |
8 |
48,817,824 |
48,839,681 |
RGD:6480464 |
CTD |
| G |
Bach2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
multiple interactions |
ISO |
5 |
48,611,805 |
48,881,943 |
RGD:6480464 |
CTD |
| G |
Bag6 |
BCL2-associated athanogene 6 |
|
multiple interactions |
ISO |
20 |
3,739,593 |
3,752,311 |
RGD:6480464 |
CTD |
| G |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
|
multiple interactions |
ISO |
10 |
109,726,243 |
109,735,724 |
RGD:6480464 |
CTD |
| G |
Bahd1 |
bromo adjacent homology domain containing 1 |
|
multiple interactions |
ISO |
3 |
105,429,028 |
105,437,536 |
RGD:6480464 |
CTD |
| G |
Bai1 |
brain-specific angiogenesis inhibitor 1 |
|
multiple interactions |
ISO |
7 |
112,622,235 |
112,682,897 |
RGD:6480464 |
CTD |
| G |
Bai2 |
brain-specific angiogenesis inhibitor 2 |
|
multiple interactions |
ISO |
5 |
149,014,053 |
149,046,244 |
RGD:6480464 |
CTD |
| G |
Baiap2 |
BAI1-associated protein 2 |
|
multiple interactions |
ISO |
10 |
109,351,201 |
109,413,703 |
RGD:6480464 |
CTD |
| G |
Bambi |
BMP and activin membrane-bound inhibitor, homolog (Xenopus laevis) |
|
multiple interactions |
ISO |
17 |
62,654,385 |
62,658,641 |
RGD:6480464 |
CTD |
| G |
Bap1 |
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) |
|
multiple interactions |
ISO |
16 |
6,684,470 |
6,693,296 |
RGD:6480464 |
CTD |
| G |
Barhl2 |
BarH-like homeobox 2 |
|
multiple interactions |
ISO |
14 |
3,888,153 |
3,893,050 |
RGD:6480464 |
CTD |
| G |
Barx1 |
BARX homeobox 1 |
|
multiple interactions |
ISO |
17 |
21,993,765 |
21,997,240 |
RGD:6480464 |
CTD |
| G |
Barx2 |
BARX homeobox 2 |
|
multiple interactions |
ISO |
8 |
31,572,341 |
31,659,306 |
RGD:6480464 |
CTD |
| G |
Batf |
basic leucine zipper transcription factor, ATF-like |
|
multiple interactions |
ISO |
6 |
109,793,076 |
109,817,614 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
|
multiple interactions |
ISO |
12 |
22,586,411 |
22,644,378 |
RGD:6480464 |
CTD |
| G |
Baz2a |
bromodomain adjacent to zinc finger domain, 2A |
|
multiple interactions |
ISO |
7 |
1,389,681 |
1,421,170 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bbs4 |
Bardet-Biedl syndrome 4 |
|
multiple interactions |
ISO |
8 |
63,153,456 |
63,189,904 |
RGD:6480464 |
CTD |
| G |
Bcam |
basal cell adhesion molecule (Lutheran blood group) |
|
multiple interactions |
ISO |
1 |
79,067,352 |
79,081,739 |
RGD:6480464 |
CTD |
| G |
Bcan |
brevican |
|
multiple interactions |
ISO |
2 |
180,067,864 |
180,080,942 |
RGD:6480464 |
CTD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
multiple interactions |
ISO |
19 |
41,646,190 |
41,669,234 |
RGD:6480464 |
CTD |
| G |
Bcar3 |
breast cancer anti-estrogen resistance 3 |
|
multiple interactions |
ISO |
2 |
219,075,206 |
219,188,344 |
RGD:6480464 |
CTD |
| G |
Bcdin3d |
BCDIN3 domain containing |
|
multiple interactions |
ISO |
7 |
138,218,542 |
138,223,136 |
RGD:6480464 |
CTD |
| G |
Bcl11a |
B-cell CLL/lymphoma 11A (zinc finger protein) |
|
multiple interactions |
ISO |
14 |
105,002,744 |
105,088,365 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
multiple interactions |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl2l14 |
Bcl2-like 14 (apoptosis facilitator) |
|
multiple interactions |
ISO |
4 |
171,283,106 |
171,325,345 |
RGD:6480464 |
CTD |
| G |
Bcl2l2 |
Bcl2-like 2 |
|
multiple interactions |
ISO |
15 |
32,983,165 |
32,988,018 |
RGD:6480464 |
CTD |
| G |
Bclaf1 |
BCL2-associated transcription factor 1 |
|
multiple interactions |
ISO |
1 |
15,605,220 |
15,632,005 |
RGD:6480464 |
CTD |
| G |
Bcor |
BCL6 co-repressor |
|
multiple interactions |
ISO |
X |
22,699,778 |
22,820,234 |
RGD:6480464 |
CTD |
| G |
Bcorl1 |
BCL6 co-repressor-like 1 |
|
multiple interactions |
ISO |
X |
134,755,840 |
134,802,339 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
multiple interactions |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Best1 |
bestrophin 1 |
|
multiple interactions |
ISO |
1 |
212,432,811 |
212,449,374 |
RGD:6480464 |
CTD |
| G |
Bex1 |
brain expressed, X-linked 1 |
|
multiple interactions |
ISO |
X |
123,527,737 |
123,529,133 |
RGD:6480464 |
CTD |
| G |
Bex2 |
brain expressed X-linked 2 |
|
multiple interactions |
ISO |
X |
123,322,594 |
123,324,122 |
RGD:6480464 |
CTD |
| G |
Bex4 |
brain expressed, X-linked 4 |
|
multiple interactions |
ISO |
X |
123,442,511 |
123,443,772 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bhlha15 |
basic helix-loop-helix family, member a15 |
|
multiple interactions |
ISO |
12 |
10,747,865 |
10,752,041 |
RGD:6480464 |
CTD |
| G |
Bhlhb9 |
basic helix-loop-helix domain containing, class B, 9 |
|
multiple interactions |
ISO |
X |
123,149,086 |
123,151,846 |
RGD:6480464 |
CTD |
| G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
multiple interactions |
ISO |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Bhmt2 |
betaine-homocysteine S-methyltransferase 2 |
|
multiple interactions |
ISO |
2 |
23,958,062 |
23,976,438 |
RGD:6480464 |
CTD |
| G |
Bicc1 |
bicaudal C homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
20 |
18,288,079 |
18,477,016 |
RGD:6480464 |
CTD |
| G |
Bin1 |
bridging integrator 1 |
|
multiple interactions |
ISO |
18 |
24,813,407 |
24,872,852 |
RGD:6480464 |
CTD |
| G |
Blnk |
B-cell linker |
|
multiple interactions |
ISO |
1 |
246,091,335 |
246,165,075 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmper |
BMP-binding endothelial regulator |
|
multiple interactions |
ISO |
8 |
22,975,570 |
23,096,066 |
RGD:6480464 |
CTD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
multiple interactions |
ISO |
9 |
58,327,587 |
58,436,057 |
RGD:6480464 |
CTD |
| G |
Bms1 |
BMS1 homolog, ribosome assembly protein (yeast) |
|
multiple interactions |
ISO |
4 |
154,687,169 |
154,721,783 |
RGD:6480464 |
CTD |
| G |
Bnc1 |
basonuclin 1 |
|
multiple interactions |
ISO |
1 |
138,189,334 |
138,201,795 |
RGD:6480464 |
CTD |
| G |
Bnip1 |
BCL2/adenovirus E1B interacting protein 1 |
|
multiple interactions |
ISO |
10 |
16,648,619 |
16,660,896 |
RGD:6480464 |
CTD |
| G |
Bphl |
biphenyl hydrolase-like (serine hydrolase) |
|
multiple interactions |
ISO |
17 |
37,143,275 |
37,181,166 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
multiple interactions |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca2 |
breast cancer 2, early onset |
|
multiple interactions |
ISO |
12 |
4,282,952 |
4,323,693 |
RGD:6480464 |
CTD |
| G |
Brd3 |
bromodomain containing 3 |
|
multiple interactions |
ISO |
3 |
6,369,903 |
6,390,116 |
RGD:6480464 |
CTD |
| G |
Brms1 |
breast cancer metastasis-suppressor 1 |
|
multiple interactions |
ISO |
1 |
207,661,537 |
207,670,801 |
RGD:6480464 |
CTD |
| G |
Brsk2 |
BR serine/threonine kinase 2 |
|
multiple interactions |
ISO |
1 |
202,083,095 |
202,133,268 |
RGD:6480464 |
CTD |
| G |
Bspry |
B-box and SPRY domain containing |
|
multiple interactions |
ISO |
5 |
79,471,061 |
79,493,239 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
multiple interactions |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg3 |
BTG family, member 3 |
|
multiple interactions |
ISO |
11 |
17,241,627 |
17,257,740 |
RGD:6480464 |
CTD |
| G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
|
multiple interactions |
ISO |
X |
121,998,935 |
122,030,289 |
RGD:6480464 |
CTD |
| G |
Btn1a1 |
butyrophilin, subfamily 1, member A1 |
|
multiple interactions |
ISO |
17 |
48,856,129 |
48,863,883 |
RGD:6480464 |
CTD |
| G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
multiple interactions |
ISO |
3 |
115,323,510 |
115,354,906 |
RGD:6480464 |
CTD |
| G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
multiple interactions |
ISO |
3 |
105,063,018 |
105,116,145 |
RGD:6480464 |
CTD |
| G |
Bves |
blood vessel epicardial substance |
|
multiple interactions |
ISO |
20 |
49,671,174 |
49,671,683 |
RGD:6480464 |
CTD |
| G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
|
multiple interactions |
ISO |
9 |
57,053,423 |
57,065,699 |
RGD:6480464 |
CTD |
| G |
Bzw2 |
basic leucine zipper and W2 domains 2 |
|
multiple interactions |
ISO |
6 |
54,817,673 |
54,881,310 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, B chain |
|
multiple interactions |
ISO |
5 |
155,647,524 |
155,653,074 |
RGD:6480464 |
CTD |
| G |
C1qtnf4 |
C1q and tumor necrosis factor related protein 4 |
|
multiple interactions |
ISO |
3 |
75,248,277 |
75,252,715 |
RGD:6480464 |
CTD |
| G |
C1qtnf6 |
C1q and tumor necrosis factor related protein 6 |
|
multiple interactions |
ISO |
7 |
116,479,791 |
116,486,309 |
RGD:6480464 |
CTD |
| G |
C1qtnf7 |
C1q and tumor necrosis factor related protein 7 |
|
multiple interactions |
ISO |
14 |
72,631,465 |
72,645,084 |
RGD:6480464 |
CTD |
| G |
C1r |
complement component 1, r subcomponent |
|
multiple interactions |
ISO |
4 |
160,712,582 |
160,729,362 |
RGD:6480464 |
CTD |
| G |
C1s |
complement component 1, s subcomponent |
|
multiple interactions |
ISO |
4 |
160,736,133 |
160,748,133 |
RGD:6480464 |
CTD |
| G |
C3ar1 |
complement component 3a receptor 1 |
|
multiple interactions |
ISO |
4 |
159,326,402 |
159,333,433 |
RGD:6480464 |
CTD |
| G |
C4b |
complement component 4B (Chido blood group) |
|
multiple interactions |
ISO |
20 |
4,300,687 |
4,315,882 |
RGD:6480464 |
CTD |
| G |
Ca10 |
carbonic anhydrase 10 |
|
multiple interactions |
ISO |
10 |
81,756,486 |
82,238,335 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
multiple interactions |
ISO |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Cabin1 |
calcineurin binding protein 1 |
|
multiple interactions |
ISO |
20 |
13,444,801 |
13,569,453 |
RGD:6480464 |
CTD |
| G |
Cables2 |
Cdk5 and Abl enzyme substrate 2 |
|
multiple interactions |
ISO |
3 |
169,312,295 |
169,327,016 |
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
multiple interactions |
ISO |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
|
multiple interactions |
ISO |
3 |
2,842,948 |
3,039,747 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
multiple interactions |
ISO |
10 |
83,043,636 |
83,112,886 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
|
multiple interactions |
ISO |
17 |
88,832,905 |
89,078,870 |
RGD:6480464 |
CTD |
| G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
|
multiple interactions |
ISO |
7 |
137,384,752 |
137,394,283 |
RGD:6480464 |
CTD |
| G |
Cadps |
Ca++-dependent secretion activator |
|
multiple interactions |
ISO |
15 |
13,859,286 |
14,319,814 |
RGD:6480464 |
CTD |
| G |
Cadps2 |
Ca++-dependent secretion activator 2 |
|
multiple interactions |
ISO |
4 |
49,658,535 |
50,206,014 |
RGD:6480464 |
CTD |
| G |
Calml4 |
calmodulin-like 4 |
|
multiple interactions |
ISO |
8 |
67,007,122 |
67,018,886 |
RGD:6480464 |
CTD |
| G |
Caln1 |
calneuron 1 |
|
multiple interactions |
ISO |
12 |
26,860,409 |
27,287,503 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
multiple interactions |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Caly |
calcyon neuron-specific vesicular protein |
|
multiple interactions |
ISO |
1 |
199,869,223 |
199,880,102 |
RGD:6480464 |
CTD |
| G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
|
multiple interactions |
ISO |
2 |
223,840,650 |
224,108,082 |
RGD:6480464 |
CTD |
| G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
|
multiple interactions |
ISO |
5 |
157,235,534 |
157,237,314 |
RGD:6480464 |
CTD |
| G |
Camkk1 |
calcium/calmodulin-dependent protein kinase kinase 1, alpha |
|
multiple interactions |
ISO |
10 |
59,908,749 |
59,932,276 |
RGD:6480464 |
CTD |
| G |
Camsap1 |
calmodulin regulated spectrin-associated protein 1 |
|
multiple interactions |
ISO |
3 |
4,098,538 |
4,159,591 |
RGD:6480464 |
CTD |
| G |
Camta1 |
calmodulin binding transcription activator 1 |
|
multiple interactions |
ISO |
5 |
168,201,249 |
169,046,038 |
RGD:6480464 |
CTD |
| G |
Cand2 |
cullin-associated and neddylation-dissociated 2 (putative) |
|
multiple interactions |
ISO |
4 |
151,912,174 |
151,940,734 |
RGD:6480464 |
CTD |
| G |
Cant1 |
calcium activated nucleotidase 1 |
|
multiple interactions |
ISO |
10 |
108,405,355 |
108,420,225 |
RGD:6480464 |
CTD |
| G |
Capg |
capping protein (actin filament), gelsolin-like |
|
multiple interactions |
ISO |
4 |
105,850,321 |
105,862,109 |
RGD:6480464 |
CTD |
| G |
Capn6 |
calpain 6 |
|
multiple interactions |
ISO |
X |
34,697,658 |
34,722,369 |
RGD:6480464 |
CTD |
| G |
Capsl |
calcyphosine-like |
|
multiple interactions |
ISO |
2 |
59,043,383 |
59,066,371 |
RGD:6480464 |
CTD |
| G |
Capzb |
capping protein (actin filament) muscle Z-line, beta |
|
multiple interactions |
ISO |
5 |
157,980,877 |
158,080,682 |
RGD:6480464 |
CTD |
| G |
Card10 |
caspase recruitment domain family, member 10 |
|
multiple interactions |
ISO |
7 |
116,737,928 |
116,766,959 |
RGD:6480464 |
CTD |
| G |
Carhsp1 |
calcium regulated heat stable protein 1 |
|
multiple interactions |
ISO |
10 |
6,986,583 |
7,000,181 |
RGD:6480464 |
CTD |
| G |
Casc5 |
cancer susceptibility candidate 5 |
|
multiple interactions |
ISO |
3 |
105,561,365 |
105,615,047 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
multiple interactions |
ISO |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casz1 |
castor zinc finger 1 |
|
multiple interactions |
ISO |
5 |
165,979,472 |
166,030,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbfa2t2 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 2 |
|
multiple interactions |
ISO |
3 |
144,904,533 |
145,007,851 |
RGD:6480464 |
CTD |
| G |
Cbln2 |
cerebellin 2 precursor |
|
multiple interactions |
ISO |
18 |
83,306,945 |
83,313,398 |
RGD:6480464 |
CTD |
| G |
Cbr3 |
carbonyl reductase 3 |
|
multiple interactions |
ISO |
11 |
33,913,961 |
33,922,221 |
RGD:6480464 |
CTD |
| G |
Cbx1 |
chromobox homolog 1 |
|
multiple interactions |
ISO |
10 |
85,544,537 |
85,564,903 |
RGD:6480464 |
CTD |
| G |
Cbx6 |
chromobox homolog 6 |
|
multiple interactions |
ISO |
7 |
118,062,267 |
118,070,004 |
RGD:6480464 |
CTD |
| G |
Cc2d1b |
coiled-coil and C2 domain containing 1B |
|
multiple interactions |
ISO |
5 |
129,906,965 |
129,920,984 |
RGD:6480464 |
CTD |
| G |
Ccbl1 |
cysteine conjugate-beta lyase, cytoplasmic |
|
increases amination |
ISO |
3 |
9,195,737 |
9,209,545 |
RGD:6480464 |
CTD |
| G |
Ccdc103 |
coiled-coil domain containing 103 |
|
multiple interactions |
ISO |
10 |
92,053,347 |
92,056,747 |
RGD:6480464 |
CTD |
| G |
Ccdc106 |
coiled-coil domain containing 106 |
|
multiple interactions |
ISO |
1 |
67,518,530 |
67,521,713 |
RGD:6480464 |
CTD |
| G |
Ccdc107 |
coiled-coil domain containing 107 |
|
multiple interactions |
ISO |
5 |
59,973,255 |
59,975,669 |
RGD:6480464 |
CTD |
| G |
Ccdc109b |
coiled-coil domain containing 109B |
|
multiple interactions |
ISO |
2 |
227,374,643 |
227,378,517 |
RGD:6480464 |
CTD |
| G |
Ccdc116 |
coiled-coil domain containing 116 |
|
multiple interactions |
ISO |
11 |
85,849,737 |
85,852,819 |
RGD:6480464 |
CTD |
| G |
Ccdc117 |
coiled-coil domain containing 117 |
|
multiple interactions |
ISO |
14 |
86,161,551 |
86,170,917 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cenpn |
centromere protein N |
|
multiple interactions |
ISO |
19 |
47,029,240 |
47,051,557 |
RGD:6480464 |
CTD |
| G |
Cep170 |
centrosomal protein 170 |
|
multiple interactions |
ISO |
13 |
92,502,346 |
92,611,568 |
RGD:6480464 |
CTD |
| G |
Cep55 |
centrosomal protein 55 |
|
multiple interactions |
ISO |
1 |
242,382,809 |
242,398,281 |
RGD:6480464 |
CTD |
| G |
Cerkl |
ceramide kinase-like |
|
multiple interactions |
ISO |
3 |
62,103,856 |
62,204,116 |
RGD:6480464 |
CTD |
| G |
Cetn3 |
centrin, EF-hand protein, 3 |
|
multiple interactions |
ISO |
2 |
9,909,950 |
9,922,361 |
RGD:6480464 |
CTD |
| G |
Cetn4 |
centrin 4 |
|
multiple interactions |
ISO |
2 |
123,857,012 |
123,860,943 |
RGD:6480464 |
CTD |
| G |
Cfdp1 |
craniofacial development protein 1 |
|
multiple interactions |
ISO |
19 |
41,703,586 |
41,792,613 |
RGD:6480464 |
CTD |
| G |
Cggbp1 |
CGG triplet repeat binding protein 1 |
|
multiple interactions |
ISO |
11 |
2,182,858 |
2,190,461 |
RGD:6480464 |
CTD |
| G |
Cgnl1 |
cingulin-like 1 |
|
multiple interactions |
ISO |
8 |
76,088,865 |
76,241,145 |
RGD:6480464 |
CTD |
| G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
|
multiple interactions |
ISO |
6 |
25,414,812 |
25,426,818 |
RGD:6480464 |
CTD |
| G |
Chac1 |
ChaC, cation transport regulator homolog 1 (E. coli) |
|
multiple interactions |
ISO |
3 |
105,869,762 |
105,873,332 |
RGD:6480464 |
CTD |
| G |
Chd1l |
chromodomain helicase DNA binding protein 1-like |
|
multiple interactions |
ISO |
2 |
192,382,644 |
192,438,157 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
multiple interactions |
ISO |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Chgb |
chromogranin B (secretogranin 1) |
|
multiple interactions |
ISO |
3 |
120,571,736 |
120,584,874 |
RGD:6480464 |
CTD |
| G |
Chi3l3 |
chitinase 3-like 3 |
|
multiple interactions |
ISO |
2 |
201,588,788 |
201,605,075 |
RGD:6480464 |
CTD |
| G |
Chmp4bl1 |
chromatin modifying protein 4B-like 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cilp2 |
cartilage intermediate layer protein 2 |
|
multiple interactions |
ISO |
16 |
20,024,989 |
20,031,984 |
RGD:6480464 |
CTD |
| G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
|
multiple interactions |
ISO |
X |
90,301,067 |
90,305,762 |
RGD:6480464 |
CTD |
| G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
|
multiple interactions |
ISO |
5 |
141,258,564 |
141,259,455 |
RGD:6480464 |
CTD |
| G |
Ckap2 |
cytoskeleton associated protein 2 |
|
multiple interactions |
ISO |
16 |
74,492,221 |
74,518,743 |
RGD:6480464 |
CTD |
| G |
Ckap2l |
cytoskeleton associated protein 2-like |
|
multiple interactions |
ISO |
3 |
116,885,189 |
116,911,173 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
multiple interactions |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Cklf |
chemokine-like factor |
|
multiple interactions |
ISO |
19 |
655,880 |
665,215 |
RGD:6480464 |
CTD |
| G |
Clca2 |
chloride channel accessory 2 |
|
multiple interactions |
ISO |
2 |
243,114,775 |
243,142,349 |
RGD:6480464 |
CTD |
| G |
Clca2 |
chloride channel accessory 2 |
|
multiple interactions |
ISO |
2 |
243,114,775 |
243,142,349 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
multiple interactions |
EXP |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
multiple interactions |
ISO |
9 |
35,625,478 |
35,627,304 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
multiple interactions |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Creg2 |
cellular repressor of E1A-stimulated genes 2 |
|
multiple interactions |
ISO |
9 |
38,698,544 |
38,830,140 |
RGD:6480464 |
CTD |
| G |
Crk |
v-crk sarcoma virus CT10 oncogene homolog (avian) |
|
multiple interactions |
ISO |
10 |
63,017,662 |
63,040,420 |
RGD:6480464 |
CTD |
| G |
Csrnp2 |
cysteine-serine-rich nuclear protein 2 |
|
multiple interactions |
ISO |
7 |
139,182,243 |
139,198,084 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
multiple interactions |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Cul1 |
cullin 1 |
|
multiple interactions |
ISO |
4 |
75,636,914 |
75,705,724 |
RGD:6480464 |
CTD |
| G |
Cul4a |
cullin 4A |
|
multiple interactions |
ISO |
16 |
81,242,293 |
81,279,498 |
RGD:6480464 |
CTD |
| G |
Cxcl16 |
chemokine (C-X-C motif) ligand 16 |
|
multiple interactions |
ISO |
10 |
57,296,126 |
57,300,721 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
multiple interactions |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cyb5r3 |
cytochrome b5 reductase 3 |
|
multiple interactions |
ISO |
7 |
121,187,821 |
121,205,382 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
multiple interactions |
ISO |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
multiple interactions |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
127,018,908 |
127,020,878 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
multiple interactions |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
multiple interactions |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dusp4 |
dual specificity phosphatase 4 |
|
multiple interactions |
ISO |
16 |
61,109,626 |
61,119,981 |
RGD:6480464 |
CTD |
| G |
Dvl2 |
dishevelled, dsh homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dym |
dymeclin |
|
multiple interactions |
ISO |
18 |
71,889,053 |
72,188,251 |
RGD:6480464 |
CTD |
| G |
Dynll1 |
dynein light chain LC8-type 1 |
|
multiple interactions |
ISO |
12 |
42,580,542 |
42,582,915 |
RGD:6480464 |
CTD |
| G |
Dynll2 |
dynein light chain LC8-type 2 |
|
multiple interactions |
ISO |
10 |
76,263,883 |
76,271,908 |
RGD:6480464 |
CTD |
| G |
Dynlt1 |
dynein light chain Tctex-type 1 |
|
multiple interactions |
ISO |
1 |
41,097,174 |
41,103,997 |
RGD:6480464 |
CTD |
| G |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A |
|
multiple interactions |
ISO |
11 |
34,879,733 |
34,970,998 |
RGD:6480464 |
CTD |
| G |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
|
multiple interactions |
ISO |
13 |
44,077,971 |
44,089,140 |
RGD:6480464 |
CTD |
| G |
Dzip1l |
DAZ interacting protein 1-like |
|
multiple interactions |
ISO |
8 |
104,507,601 |
104,542,280 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
multiple interactions |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
Eaf2 |
ELL associated factor 2 |
|
multiple interactions |
ISO |
11 |
65,763,410 |
65,809,967 |
RGD:6480464 |
CTD |
| G |
Ebf1 |
early B-cell factor 1 |
|
multiple interactions |
ISO |
10 |
29,770,047 |
30,163,200 |
RGD:6480464 |
CTD |
| G |
Ebf2 |
early B-cell factor 2 |
|
multiple interactions |
ISO |
15 |
46,779,220 |
46,977,125 |
RGD:6480464 |
CTD |
| G |
Ebi3 |
Epstein-Barr virus induced 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ebpl |
emopamil binding protein-like |
|
multiple interactions |
ISO |
15 |
40,484,464 |
40,506,451 |
RGD:6480464 |
CTD |
| G |
Ece1 |
endothelin converting enzyme 1 |
|
multiple interactions |
ISO |
5 |
156,635,656 |
156,735,783 |
RGD:6480464 |
CTD |
| G |
Ece2 |
endothelin-converting enzyme 2 |
|
multiple interactions |
ISO |
11 |
82,492,975 |
82,507,876 |
RGD:6480464 |
CTD |
| G |
Ech1 |
enoyl CoA hydratase 1, peroxisomal |
|
multiple interactions |
ISO |
1 |
83,932,720 |
83,938,918 |
RGD:6480464 |
CTD |
| G |
Echdc1 |
enoyl CoA hydratase domain containing 1 |
|
multiple interactions |
ISO |
1 |
29,266,332 |
29,296,530 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
multiple interactions |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
multiple interactions |
ISO |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
|
multiple interactions |
ISO |
1 |
211,640,954 |
211,651,560 |
RGD:6480464 |
CTD |
| G |
Eef2k |
eukaryotic elongation factor-2 kinase |
|
multiple interactions |
ISO |
1 |
179,712,404 |
179,754,345 |
RGD:6480464 |
CTD |
| G |
Efhc1 |
EF-hand domain (C-terminal) containing 1 |
|
multiple interactions |
ISO |
9 |
19,695,815 |
19,750,261 |
RGD:6480464 |
CTD |
| G |
Efhd1 |
EF-hand domain family, member D1 |
|
multiple interactions |
ISO |
9 |
86,076,009 |
86,124,552 |
RGD:6480464 |
CTD |
| G |
Efna1 |
ephrin A1 |
|
multiple interactions |
ISO |
2 |
181,444,599 |
181,451,944 |
RGD:6480464 |
CTD |
| G |
Efna2 |
ephrin A2 |
|
multiple interactions |
ISO |
7 |
11,028,432 |
11,039,064 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Ercc6 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 |
|
multiple interactions |
ISO |
16 |
8,024,881 |
8,091,587 |
RGD:6480464 |
CTD |
| G |
Ercc6l |
excision repair cross-complementing rodent repair deficiency complementation group 6 - like |
|
multiple interactions |
ISO |
X |
90,195,080 |
90,212,006 |
RGD:6480464 |
CTD |
| G |
Evi2a |
ecotropic viral integration site 2A |
|
multiple interactions |
ISO |
10 |
65,713,406 |
65,717,306 |
RGD:6480464 |
CTD |
| G |
Evl |
Enah/Vasp-like |
|
multiple interactions |
ISO |
6 |
132,952,804 |
133,019,870 |
RGD:6480464 |
CTD |
| G |
Evpl |
envoplakin |
|
multiple interactions |
ISO |
10 |
106,336,953 |
106,353,217 |
RGD:6480464 |
CTD |
| G |
Evx1 |
even-skipped homeobox 1 |
|
multiple interactions |
ISO |
4 |
80,616,465 |
80,620,842 |
RGD:6480464 |
CTD |
| G |
Exd1 |
exonuclease 3'-5' domain containing 1 |
|
multiple interactions |
ISO |
3 |
106,038,460 |
106,066,302 |
RGD:6480464 |
CTD |
| G |
Exo1 |
exonuclease 1 |
|
multiple interactions |
ISO |
13 |
91,619,024 |
91,644,366 |
RGD:6480464 |
CTD |
| G |
Exoc7 |
exocyst complex component 7 |
|
multiple interactions |
ISO |
10 |
106,400,889 |
106,419,793 |
RGD:6480464 |
CTD |
| G |
Exoc8 |
exocyst complex component 8 |
|
multiple interactions |
ISO |
19 |
55,066,272 |
55,068,761 |
RGD:6480464 |
CTD |
| G |
Exosc4 |
exosome component 4 |
|
multiple interactions |
ISO |
7 |
114,374,913 |
114,377,655 |
RGD:6480464 |
CTD |
| G |
Exosc8 |
exosome component 8 |
|
multiple interactions |
ISO |
2 |
143,954,943 |
143,961,239 |
RGD:6480464 |
CTD |
| G |
Exph5 |
exophilin 5 |
|
multiple interactions |
ISO |
8 |
56,762,507 |
56,835,516 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
multiple interactions |
ISO |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
multiple interactions |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
Fa2h |
fatty acid 2-hydroxylase |
|
multiple interactions |
ISO |
19 |
41,268,120 |
41,319,682 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
multiple interactions |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
multiple interactions |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Foxc2 |
forkhead box C2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Foxp4 |
forkhead box P4 |
|
multiple interactions |
ISO |
9 |
8,509,028 |
8,579,597 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
decreases expression |
ISO |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
multiple interactions |
ISO |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
decreases expression |
ISO |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
decreases expression |
ISO |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
multiple interactions |
ISO |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gli3 |
GLI family zinc finger 3 |
|
multiple interactions |
ISO |
17 |
57,594,102 |
57,867,710 |
RGD:6480464 |
CTD |
| G |
Glo1 |
glyoxalase 1 |
|
multiple interactions |
ISO |
20 |
8,900,984 |
8,919,001 |
RGD:6480464 |
CTD |
| G |
Gltp |
glycolipid transfer protein |
|
multiple interactions |
ISO |
12 |
43,195,541 |
43,215,694 |
RGD:6480464 |
CTD |
| G |
Gpc1 |
glypican 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpr126 |
G protein-coupled receptor 126 |
|
multiple interactions |
ISO |
1 |
9,290,306 |
9,402,175 |
RGD:6480464 |
CTD |
| G |
Gpr155 |
G protein-coupled receptor 155 |
|
multiple interactions |
ISO |
3 |
55,846,337 |
55,900,086 |
RGD:6480464 |
CTD |
| G |
Gpr160 |
G protein-coupled receptor 160 |
|
multiple interactions |
ISO |
2 |
116,904,283 |
116,961,732 |
RGD:6480464 |
CTD |
| G |
Gpr176 |
G protein-coupled receptor 176 |
|
multiple interactions |
ISO |
3 |
104,699,853 |
104,801,217 |
RGD:6480464 |
CTD |
| G |
Gpr180 |
G protein-coupled receptor 180 |
|
multiple interactions |
ISO |
15 |
102,931,713 |
102,955,239 |
RGD:6480464 |
CTD |
| G |
Gpr50 |
G protein-coupled receptor 50 |
|
multiple interactions |
ISO |
X |
157,101,726 |
157,106,312 |
RGD:6480464 |
CTD |
| G |
Gpr6 |
G protein-coupled receptor 6 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpr64 |
G protein-coupled receptor 64 |
|
multiple interactions |
ISO |
X |
55,585,378 |
55,658,340 |
RGD:6480464 |
CTD |
| G |
Gpr65 |
G-protein coupled receptor 65 |
|
multiple interactions |
ISO |
6 |
122,432,615 |
122,433,628 |
RGD:6480464 |
CTD |
| G |
Gpr84 |
G protein-coupled receptor 84 |
|
multiple interactions |
ISO |
7 |
142,217,811 |
142,220,004 |
RGD:6480464 |
CTD |
| G |
Gpr98 |
G protein-coupled receptor 98 |
|
multiple interactions |
ISO |
2 |
8,851,539 |
8,915,885 |
RGD:6480464 |
CTD |
| G |
Gpsm3 |
G-protein signaling modulator 3 |
|
multiple interactions |
ISO |
20 |
4,259,883 |
4,261,744 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
multiple interactions |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
multiple interactions |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Gpx6 |
glutathione peroxidase 6 |
|
multiple interactions |
ISO |
17 |
51,063,379 |
51,068,058 |
RGD:6480464 |
CTD |
| G |
Gramd1b |
GRAM domain containing 1B |
|
multiple interactions |
ISO |
8 |
43,260,379 |
43,429,258 |
RGD:6480464 |
CTD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
multiple interactions |
ISO |
14 |
92,814,797 |
92,911,442 |
RGD:6480464 |
CTD |
| G |
Grhl1 |
grainyhead-like 1 (Drosophila) |
|
multiple interactions |
ISO |
6 |
42,217,279 |
42,260,621 |
RGD:6480464 |
CTD |
| G |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
|
multiple interactions |
ISO |
16 |
10,473,353 |
11,202,161 |
RGD:6480464 |
CTD |
| G |
Grid2ip |
glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein |
|
multiple interactions |
ISO |
12 |
11,525,112 |
11,554,837 |
RGD:6480464 |
CTD |
| G |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
|
multiple interactions |
ISO |
5 |
144,842,374 |
145,058,047 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
multiple interactions |
ISO |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin2c |
glutamate receptor, ionotropic, N-methyl D-aspartate 2C |
|
multiple interactions |
ISO |
10 |
105,323,371 |
105,340,976 |
RGD:6480464 |
CTD |
| G |
Grin3a |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A |
|
multiple interactions |
ISO |
5 |
66,406,451 |
66,602,353 |
RGD:6480464 |
CTD |
| G |
Gripap1 |
GRIP1 associated protein 1 |
|
multiple interactions |
ISO |
X |
26,713,439 |
26,743,461 |
RGD:6480464 |
CTD |
| G |
Grm4 |
glutamate receptor, metabotropic 4 |
|
multiple interactions |
ISO |
20 |
5,627,733 |
5,727,274 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
multiple interactions |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
multiple interactions |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
multiple interactions |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
multiple interactions |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gtf2h5 |
general transcription factor IIH, polypeptide 5 |
|
multiple interactions |
ISO |
1 |
40,858,997 |
40,865,571 |
RGD:6480464 |
CTD |
| G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
|
multiple interactions |
ISO |
10 |
31,585,703 |
31,610,825 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
multiple interactions |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hbp1 |
HMG-box transcription factor 1 |
|
multiple interactions |
ISO |
6 |
50,201,281 |
50,227,095 |
RGD:6480464 |
CTD |
| G |
Hcfc1 |
host cell factor C1 |
|
multiple interactions |
ISO |
X |
159,875,671 |
159,900,536 |
RGD:6480464 |
CTD |
| G |
Hcn4 |
hyperpolarization activated cyclic nucleotide-gated potassium channel 4 |
|
multiple interactions |
ISO |
8 |
62,629,828 |
62,667,248 |
RGD:6480464 |
CTD |
| G |
Hcrtr1 |
hypocretin (orexin) receptor 1 |
|
multiple interactions |
ISO |
5 |
149,160,739 |
149,170,736 |
RGD:6480464 |
CTD |
| G |
Hcst |
hematopoietic cell signal transducer |
|
multiple interactions |
ISO |
1 |
85,369,349 |
85,371,383 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
multiple interactions |
ISO |
20 |
41,162,093 |
41,186,492 |
RGD:6480464 |
CTD |
| G |
Helb |
helicase (DNA) B |
|
multiple interactions |
ISO |
7 |
59,311,833 |
59,338,961 |
RGD:6480464 |
CTD |
| G |
Helq |
helicase, POLQ-like |
|
multiple interactions |
ISO |
14 |
10,102,501 |
10,137,153 |
RGD:6480464 |
CTD |
| G |
Hes1 |
hairy and enhancer of split 1 (Drosophila) |
|
multiple interactions |
ISO |
11 |
72,603,482 |
72,605,673 |
RGD:6480464 |
CTD |
| G |
Hexb |
hexosaminidase B |
|
multiple interactions |
ISO |
2 |
27,649,188 |
27,672,231 |
RGD:6480464 |
CTD |
| G |
Hexim2 |
hexamethylene bis-acetamide inducible 2 |
|
multiple interactions |
ISO |
10 |
92,306,494 |
92,312,256 |
RGD:6480464 |
CTD |
| G |
Hey1 |
hairy/enhancer-of-split related with YRPW motif 1 |
|
multiple interactions |
ISO |
2 |
95,174,030 |
95,176,430 |
RGD:6480464 |
CTD |
| G |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
|
multiple interactions |
ISO |
1 |
27,505,117 |
27,515,204 |
RGD:6480464 |
CTD |
| G |
Heyl |
hairy/enhancer-of-split related with YRPW motif-like |
|
multiple interactions |
ISO |
5 |
142,544,185 |
142,561,176 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions |
ISO |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hnmt |
histamine N-methyltransferase |
|
multiple interactions |
ISO |
3 |
2,057,938 |
2,089,955 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
multiple interactions |
ISO |
8 |
20,259,178 |
20,266,351 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
affects abundance |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
LOC100362819 |
autism susceptibility candidate 2-like |
|
multiple interactions |
ISO |
12 |
26,069,494 |
26,166,764 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases activity |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mcu |
mitochondrial calcium uniporter |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mecp2 |
methyl CpG binding protein 2 |
|
multiple interactions |
ISO |
X |
159,980,599 |
160,035,260 |
RGD:6480464 |
CTD |
| G |
Mef2a |
myocyte enhancer factor 2a |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
increases expression |
ISO |
20 |
13,191,986 |
13,192,851 |
RGD:6480464 |
CTD |
| G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
affects abundance |
ISO |
17 |
5,086,219 |
5,118,086 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nebl |
nebulette |
|
multiple interactions |
ISO |
17 |
91,518,949 |
91,626,869 |
RGD:6480464 |
CTD |
| G |
Neurl1a |
neuralized homolog 1A (Drosophila) |
|
multiple interactions |
ISO |
1 |
252,502,664 |
252,573,249 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
multiple interactions |
ISO |
5 |
151,524,685 |
151,528,000 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Pcca |
propionyl CoA carboxylase, alpha polypeptide |
|
multiple interactions |
ISO |
15 |
107,659,723 |
108,028,929 |
RGD:6480464 |
CTD |
| G |
Pde10a |
phosphodiesterase 10A |
|
multiple interactions |
ISO |
1 |
46,392,900 |
46,589,076 |
RGD:6480464 |
CTD |
| G |
Pde1b |
phosphodiesterase 1B, calmodulin-dependent |
|
multiple interactions |
ISO |
7 |
142,401,489 |
142,427,626 |
RGD:6480464 |
CTD |
| G |
Pde4dip |
phosphodiesterase 4D interacting protein |
|
multiple interactions |
ISO |
2 |
192,534,747 |
192,671,053 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
multiple interactions |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
multiple interactions |
EXP |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
multiple interactions |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfc |
platelet derived growth factor C |
|
multiple interactions |
ISO |
2 |
172,635,732 |
172,811,004 |
RGD:6480464 |
CTD |
| G |
Pdgfd |
platelet derived growth factor D |
|
multiple interactions |
ISO |
8 |
3,326,218 |
3,341,300 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
multiple interactions |
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
decreases expression |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdhx |
pyruvate dehydrogenase complex, component X |
|
multiple interactions |
ISO |
3 |
88,240,250 |
88,270,914 |
RGD:6480464 |
CTD |
| G |
Pdhx |
pyruvate dehydrogenase complex, component X |
|
multiple interactions |
ISO |
3 |
88,240,250 |
88,270,914 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pdk3 |
pyruvate dehydrogenase kinase, isozyme 3 |
|
multiple interactions |
ISO |
X |
81,104,667 |
81,171,536 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
multiple interactions |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdlim3 |
PDZ and LIM domain 3 |
|
multiple interactions |
ISO |
16 |
49,637,068 |
49,668,802 |
RGD:6480464 |
CTD |
| G |
Pdlim7 |
PDZ and LIM domain 7 |
|
multiple interactions |
ISO |
17 |
15,168,835 |
15,183,983 |
RGD:6480464 |
CTD |
| G |
Pdp1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
|
multiple interactions |
ISO |
5 |
26,234,414 |
26,240,301 |
RGD:6480464 |
CTD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
|
multiple interactions |
ISO |
20 |
10,541,656 |
10,563,199 |
RGD:6480464 |
CTD |
| G |
Pdzd4 |
PDZ domain containing 4 |
|
multiple interactions |
ISO |
X |
159,716,489 |
159,746,210 |
RGD:6480464 |
CTD |
| G |
Pdzrn3 |
PDZ domain containing RING finger 3 |
|
multiple interactions |
ISO |
4 |
136,044,210 |
136,254,969 |
RGD:6480464 |
CTD |
| G |
Pea15 |
phosphoprotein enriched in astrocytes 15 |
|
multiple interactions |
ISO |
13 |
88,187,674 |
88,197,296 |
RGD:6480464 |
CTD |
| G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
|
multiple interactions |
ISO |
12 |
40,491,393 |
40,495,593 |
RGD:6480464 |
CTD |
| G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
|
multiple interactions |
ISO |
14 |
101,870,272 |
101,924,228 |
RGD:6480464 |
CTD |
| G |
Peli3 |
pellino E3 ubiquitin protein ligase family member 3 |
|
multiple interactions |
ISO |
1 |
207,548,086 |
207,558,715 |
RGD:6480464 |
CTD |
| G |
Per3 |
period circadian clock 3 |
|
multiple interactions |
ISO |
5 |
168,152,693 |
168,187,442 |
RGD:6480464 |
CTD |
| G |
Pes1 |
pescadillo ribosomal biogenesis factor 1 |
|
multiple interactions |
ISO |
14 |
84,616,451 |
84,632,831 |
RGD:6480464 |
CTD |
| G |
Pex11g |
peroxisomal biogenesis factor 11 gamma |
|
multiple interactions |
ISO |
12 |
2,702,761 |
2,709,897 |
RGD:6480464 |
CTD |
| G |
Pex12 |
peroxisomal biogenesis factor 12 |
|
multiple interactions |
ISO |
10 |
71,378,818 |
71,382,448 |
RGD:6480464 |
CTD |
| G |
Pf4 |
platelet factor 4 |
|
multiple interactions |
ISO |
14 |
18,812,550 |
18,813,259 |
RGD:6480464 |
CTD |
| G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
|
multiple interactions |
ISO |
13 |
43,624,838 |
43,652,660 |
RGD:6480464 |
CTD |
| G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
|
multiple interactions |
ISO |
8 |
114,012,543 |
114,050,534 |
RGD:6480464 |
CTD |
| G |
Pfkp |
phosphofructokinase, platelet |
|
multiple interactions |
ISO |
17 |
74,760,912 |
74,823,046 |
RGD:6480464 |
CTD |
| G |
Pfn4 |
profilin family, member 4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pgam5 |
phosphoglycerate mutase family member 5 |
|
multiple interactions |
ISO |
12 |
46,555,416 |
46,562,477 |
RGD:6480464 |
CTD |
| G |
Pgbd5 |
piggyBac transposable element derived 5 |
|
multiple interactions |
ISO |
19 |
54,542,070 |
54,608,511 |
RGD:6480464 |
CTD |
| G |
Pgc |
progastricsin (pepsinogen C) |
|
multiple interactions |
ISO |
9 |
8,723,620 |
8,731,837 |
RGD:6480464 |
CTD |
| G |
Pgd |
phosphogluconate dehydrogenase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pgf |
placental growth factor |
|
multiple interactions |
ISO |
6 |
109,215,540 |
109,226,122 |
RGD:6480464 |
CTD |
| G |
Pgls |
6-phosphogluconolactonase |
|
multiple interactions |
ISO |
16 |
18,791,241 |
18,796,727 |
RGD:6480464 |
CTD |
| G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
|
multiple interactions |
ISO |
1 |
78,235,474 |
78,240,665 |
RGD:6480464 |
CTD |
| G |
Pgm2l1 |
phosphoglucomutase 2-like 1 |
|
multiple interactions |
ISO |
1 |
157,605,906 |
157,655,227 |
RGD:6480464 |
CTD |
| G |
Pgm3 |
phosphoglucomutase 3 |
|
multiple interactions |
ISO |
8 |
91,810,223 |
91,827,293 |
RGD:6480464 |
CTD |
| G |
Pgm5 |
phosphoglucomutase 5 |
|
multiple interactions |
ISO |
1 |
228,107,411 |
228,300,939 |
RGD:6480464 |
CTD |
| G |
Pgpep1 |
pyroglutamyl-peptidase I |
|
multiple interactions |
ISO |
16 |
19,276,650 |
19,285,828 |
RGD:6480464 |
CTD |
| G |
Phb2 |
prohibitin 2 |
|
multiple interactions |
ISO |
4 |
160,835,328 |
160,839,933 |
RGD:6480464 |
CTD |
| G |
Phc1 |
polyhomeotic homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
4 |
158,736,736 |
158,759,429 |
RGD:6480464 |
CTD |
| G |
Phc3 |
polyhomeotic homolog 3 (Drosophila) |
|
multiple interactions |
ISO |
2 |
116,831,190 |
116,895,396 |
RGD:6480464 |
CTD |
| G |
Phf8 |
PHD finger protein 8 |
|
multiple interactions |
ISO |
X |
40,869,942 |
40,970,244 |
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
multiple interactions |
ISO |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Phka1 |
phosphorylase kinase, alpha 1 |
|
multiple interactions |
ISO |
X |
90,553,527 |
90,692,073 |
RGD:6480464 |
CTD |
| G |
Phlda3 |
pleckstrin homology-like domain, family A, member 3 |
|
multiple interactions |
ISO |
13 |
48,789,678 |
48,793,999 |
RGD:6480464 |
CTD |
| G |
Phldb1 |
pleckstrin homology-like domain, family B, member 1 |
|
multiple interactions |
ISO |
8 |
47,645,164 |
47,686,143 |
RGD:6480464 |
CTD |
| G |
Phldb3 |
pleckstrin homology-like domain, family B, member 3 |
|
multiple interactions |
ISO |
1 |
79,893,173 |
79,910,727 |
RGD:6480464 |
CTD |
| G |
Plcd1 |
phospholipase C, delta 1 |
|
multiple interactions |
ISO |
8 |
124,023,090 |
124,052,193 |
RGD:6480464 |
CTD |
| G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
multiple interactions |
ISO |
8 |
97,525,279 |
97,623,152 |
RGD:6480464 |
CTD |
| G |
Plscr1 |
phospholipid scramblase 1 |
|
multiple interactions |
ISO |
8 |
97,206,388 |
97,226,725 |
RGD:6480464 |
CTD |
| G |
Plxdc2 |
plexin domain containing 2 |
|
multiple interactions |
ISO |
17 |
90,572,391 |
90,982,074 |
RGD:6480464 |
CTD |
| G |
Plxna3 |
plexin A3 |
|
multiple interactions |
ISO |
X |
160,261,781 |
160,277,570 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
multiple interactions |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pmf1 |
polyamine-modulated factor 1 |
|
multiple interactions |
ISO |
2 |
180,492,380 |
180,511,936 |
RGD:6480464 |
CTD |
| G |
Pmm2 |
phosphomannomutase 2 |
|
multiple interactions |
ISO |
10 |
7,001,340 |
7,022,517 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
multiple interactions |
ISO |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Pnck |
pregnancy upregulated non-ubiquitously expressed CaM kinase |
|
multiple interactions |
ISO |
X |
45,741,127 |
45,741,920 |
RGD:6480464 |
CTD |
| G |
Pnkd |
paroxysmal nonkinesigenic dyskinesia |
|
multiple interactions |
ISO |
9 |
73,611,610 |
73,697,690 |
RGD:6480464 |
CTD |
| G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
|
multiple interactions |
ISO |
1 |
201,641,939 |
201,647,021 |
RGD:6480464 |
CTD |
| G |
Pnpla8 |
patatin-like phospholipase domain containing 8 |
|
multiple interactions |
ISO |
6 |
63,644,462 |
63,676,544 |
RGD:6480464 |
CTD |
| G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
5 |
49,544,328 |
49,547,367 |
RGD:6480464 |
CTD |
| G |
Podxl2 |
podocalyxin-like 2 |
|
multiple interactions |
ISO |
4 |
122,937,318 |
122,969,158 |
RGD:6480464 |
CTD |
| G |
Pogz |
pogo transposable element with ZNF domain |
|
multiple interactions |
ISO |
2 |
189,748,657 |
189,776,355 |
RGD:6480464 |
CTD |
| G |
Pola1 |
polymerase (DNA directed), alpha 1, catalytic subunit |
|
multiple interactions |
ISO |
X |
80,650,454 |
80,965,833 |
RGD:6480464 |
CTD |
| G |
Pole2 |
polymerase (DNA directed), epsilon 2, accessory subunit |
|
multiple interactions |
ISO |
6 |
91,155,518 |
91,180,121 |
RGD:6480464 |
CTD |
| G |
Pole3 |
polymerase (DNA directed), epsilon 3, accessory subunit |
|
multiple interactions |
ISO |
5 |
79,517,590 |
79,520,825 |
RGD:6480464 |
CTD |
| G |
Poli |
polymerase (DNA directed), iota |
|
multiple interactions |
ISO |
18 |
67,212,984 |
67,230,580 |
RGD:6480464 |
CTD |
| G |
Polr1a |
polymerase (RNA) I polypeptide A |
|
multiple interactions |
ISO |
4 |
105,187,426 |
105,251,385 |
RGD:6480464 |
CTD |
| G |
Polr2a |
polymerase (RNA) II (DNA directed) polypeptide A |
|
multiple interactions |
ISO |
10 |
56,552,872 |
56,579,172 |
RGD:6480464 |
CTD |
| G |
Polr2e |
polymerase (RNA) II (DNA directed) polypeptide E |
|
multiple interactions |
ISO |
7 |
11,179,283 |
11,183,205 |
RGD:6480464 |
CTD |
| G |
Polr3b |
polymerase (RNA) III (DNA directed) polypeptide B |
|
multiple interactions |
ISO |
7 |
21,167,374 |
21,271,601 |
RGD:6480464 |
CTD |
| G |
Polr3d |
polymerase (RNA) III (DNA directed) polypeptide D |
|
multiple interactions |
ISO |
15 |
50,838,153 |
50,842,822 |
RGD:6480464 |
CTD |
| G |
Pomgnt1 |
protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase |
|
multiple interactions |
ISO |
5 |
136,429,379 |
136,439,254 |
RGD:6480464 |
CTD |
| G |
Postn |
periostin, osteoblast specific factor |
|
multiple interactions |
ISO |
2 |
143,537,099 |
143,568,341 |
RGD:6480464 |
CTD |
| G |
Pot1b |
protection of telomeres 1B |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pou2f2 |
POU class 2 homeobox 2 |
|
multiple interactions |
ISO |
1 |
80,405,061 |
80,442,677 |
RGD:6480464 |
CTD |
| G |
Pou3f1 |
POU class 3 homeobox 1 |
|
multiple interactions |
ISO |
5 |
143,981,547 |
143,984,527 |
RGD:6480464 |
CTD |
| G |
Pou4f2 |
POU class 4 homeobox 2 |
|
multiple interactions |
ISO |
19 |
31,388,907 |
31,392,548 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
multiple interactions |
ISO |
5 |
126,121,416 |
126,197,099 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppif |
peptidylprolyl isomerase F |
|
multiple interactions |
ISO |
16 |
1,292,835 |
1,299,556 |
RGD:6480464 |
CTD |
| G |
Ppl |
periplakin |
|
multiple interactions |
ISO |
10 |
10,566,823 |
10,612,474 |
RGD:6480464 |
CTD |
| G |
Ppm1a |
protein phosphatase, Mg2+/Mn2+ dependent, 1A |
|
multiple interactions |
ISO |
6 |
95,162,067 |
95,198,936 |
RGD:6480464 |
CTD |
| G |
Ppm1d |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
|
multiple interactions |
ISO |
10 |
73,575,506 |
73,612,063 |
RGD:6480464 |
CTD |
| G |
Ppm1l |
protein phosphatase, Mg2+/Mn2+ dependent, 1L |
|
multiple interactions |
ISO |
2 |
159,385,829 |
159,662,846 |
RGD:6480464 |
CTD |
| G |
Ppp1ca |
protein phosphatase 1, catalytic subunit, alpha isozyme |
|
multiple interactions |
ISO |
1 |
206,774,719 |
206,778,336 |
RGD:6480464 |
CTD |
| G |
Ppp1r10 |
protein phosphatase 1, regulatory subunit 10 |
|
multiple interactions |
ISO |
20 |
2,940,605 |
2,984,636 |
RGD:6480464 |
CTD |
| G |
Ppp1r14a |
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
|
multiple interactions |
ISO |
1 |
84,421,638 |
84,427,235 |
RGD:6480464 |
CTD |
| G |
Ppp1r15b |
protein phosphatase 1, regulatory subunit 15B |
|
multiple interactions |
ISO |
13 |
46,039,831 |
46,047,636 |
RGD:6480464 |
CTD |
| G |
Ppp1r16b |
protein phosphatase 1, regulatory subunit 16B |
|
multiple interactions |
ISO |
3 |
149,404,662 |
149,496,290 |
RGD:6480464 |
CTD |
| G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
|
multiple interactions |
ISO |
1 |
240,991,884 |
240,996,887 |
RGD:6480464 |
CTD |
| G |
Ppp1r9a |
protein phosphatase 1, regulatory subunit 9A |
|
multiple interactions |
ISO |
4 |
29,654,468 |
29,928,476 |
RGD:6480464 |
CTD |
| G |
Ppp1r9b |
protein phosphatase 1, regulatory subunit 9B |
|
multiple interactions |
ISO |
10 |
83,674,797 |
83,690,639 |
RGD:6480464 |
CTD |
| G |
Ppp2ca |
protein phosphatase 2, catalytic subunit, alpha isozyme |
|
multiple interactions |
ISO |
10 |
37,621,256 |
37,641,008 |
RGD:6480464 |
CTD |
| G |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
|
multiple interactions |
ISO |
14 |
79,417,924 |
79,460,075 |
RGD:6480464 |
CTD |
| G |
Ppp2r5a |
protein phosphatase 2, regulatory subunit B', alpha |
|
multiple interactions |
ISO |
13 |
107,413,761 |
107,458,156 |
RGD:6480464 |
CTD |
| G |
Ppp2r5e |
protein phosphatase 2, regulatory subunit B', epsilon isoform |
|
multiple interactions |
ISO |
6 |
98,047,316 |
98,197,549 |
RGD:6480464 |
CTD |
| G |
Ppp3cc |
protein phosphatase 3, catalytic subunit, gamma isozyme |
|
multiple interactions |
ISO |
15 |
50,616,635 |
50,688,593 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
multiple interactions |
ISO |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Rab1b |
RAB1B, member RAS oncogene family |
|
multiple interactions |
ISO |
1 |
207,720,833 |
207,727,458 |
RGD:6480464 |
CTD |
| G |
Rab1b-ps1 |
RAB1B, member RAS oncogene family, pseudogene 1 |
|
multiple interactions |
ISO |
X |
73,108,011 |
73,109,857 |
RGD:6480464 |
CTD |
| G |
Rab9a |
RAB9A, member RAS oncogene family |
|
multiple interactions |
ISO |
X |
48,663,349 |
48,686,805 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
multiple interactions |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
increases methylation |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
multiple interactions |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
multiple interactions |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
increases methylation |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
RGD1561778 |
similar to dendritic cell-derived immunoglobulin(Ig)-like receptor 1, DIgR1 - mouse |
|
multiple interactions |
ISO |
10 |
105,084,608 |
105,089,307 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Sema3b |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
|
multiple interactions |
ISO |
8 |
112,845,709 |
112,852,565 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
|
decreases expression |
EXP |
7 |
127,817,026 |
127,877,875 |
RGD:6480464 |
CTD |
| G |
Sla |
src-like adaptor |
|
multiple interactions |
ISO |
7 |
104,153,028 |
104,202,272 |
RGD:6480464 |
CTD |
| G |
Slamf7 |
SLAM family member 7 |
|
multiple interactions |
ISO |
13 |
87,637,105 |
87,653,930 |
RGD:6480464 |
CTD |
| G |
Slc10a2 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 2 |
|
multiple interactions |
ISO |
16 |
89,939,295 |
89,961,444 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
multiple interactions |
ISO |
18 |
53,673,215 |
53,741,352 |
RGD:6480464 |
CTD |
| G |
Slc12a4 |
solute carrier family 12 (potassium/chloride transporters), member 4 |
|
multiple interactions |
ISO |
19 |
35,785,181 |
35,807,024 |
RGD:6480464 |
CTD |
| G |
Slc12a5 |
solute carrier family 12 (potassium-chloride transporter), member 5 |
|
multiple interactions |
ISO |
3 |
156,006,017 |
156,037,915 |
RGD:6480464 |
CTD |
| G |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
|
multiple interactions |
ISO |
11 |
68,934,104 |
69,087,168 |
RGD:6480464 |
CTD |
| G |
Slc13a3 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 |
|
multiple interactions |
ISO |
3 |
156,447,900 |
156,510,620 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
multiple interactions |
ISO |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc16a10 |
solute carrier family 16, member 10 (aromatic amino acid transporter) |
|
multiple interactions |
ISO |
20 |
44,211,651 |
44,325,332 |
RGD:6480464 |
CTD |
| G |
Slc16a3 |
solute carrier family 16, member 3 (monocarboxylic acid transporter 4) |
|
multiple interactions |
ISO |
10 |
110,159,679 |
110,163,182 |
RGD:6480464 |
CTD |
| G |
Slc16a6 |
solute carrier family 16, member 6 (monocarboxylic acid transporter 7) |
|
multiple interactions |
ISO |
10 |
98,853,289 |
98,875,189 |
RGD:6480464 |
CTD |
| G |
Slc16a8 |
solute carrier family 16, member 8 (monocarboxylic acid transporter 3) |
|
multiple interactions |
ISO |
7 |
117,234,094 |
117,237,887 |
RGD:6480464 |
CTD |
| G |
Slc17a3 |
solute carrier family 17 (sodium phosphate), member 3 |
|
multiple interactions |
ISO |
17 |
48,599,049 |
48,620,786 |
RGD:6480464 |
CTD |
| G |
Slc17a8 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 |
|
multiple interactions |
ISO |
7 |
26,361,488 |
26,413,820 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
multiple interactions |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions |
ISO |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a2 |
solute carrier family 19 (thiamine transporter), member 2 |
|
multiple interactions |
ISO |
13 |
80,017,780 |
80,031,777 |
RGD:6480464 |
CTD |
| G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
|
multiple interactions |
ISO |
1 |
77,111,082 |
77,125,166 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
multiple interactions |
ISO |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc22a17 |
solute carrier family 22, member 17 |
|
multiple interactions |
ISO |
15 |
33,008,690 |
33,015,184 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
multiple interactions |
ISO |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Slc24a3 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
|
multiple interactions |
ISO |
3 |
133,734,890 |
134,249,326 |
RGD:6480464 |
CTD |
| G |
Slc25a1 |
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1 |
|
multiple interactions |
ISO |
11 |
85,043,902 |
85,046,919 |
RGD:6480464 |
CTD |
| G |
Slc25a23 |
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slc25a24 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24 |
|
multiple interactions |
ISO |
2 |
204,721,524 |
204,760,766 |
RGD:6480464 |
CTD |
| G |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
|
multiple interactions |
ISO |
3 |
11,539,415 |
11,549,538 |
RGD:6480464 |
CTD |
| G |
Slc25a27 |
solute carrier family 25, member 27 |
|
multiple interactions |
ISO |
9 |
13,002,823 |
13,028,534 |
RGD:6480464 |
CTD |
| G |
Slc25a29 |
solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
|
multiple interactions |
ISO |
6 |
133,166,812 |
133,177,600 |
RGD:6480464 |
CTD |
| G |
Slc25a36 |
solute carrier family 25 (pyrimidine nucleotide carrier ), member 36 |
|
multiple interactions |
ISO |
8 |
102,160,470 |
102,191,368 |
RGD:6480464 |
CTD |
| G |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
|
multiple interactions |
ISO |
16 |
49,353,476 |
49,357,271 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
multiple interactions |
ISO |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc30a9 |
solute carrier family 30 (zinc transporter), member 9 |
|
multiple interactions |
ISO |
14 |
43,423,677 |
43,477,106 |
RGD:6480464 |
CTD |
| G |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
|
multiple interactions |
ISO |
3 |
149,342,399 |
149,347,124 |
RGD:6480464 |
CTD |
| G |
Slc35a3 |
solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 |
|
multiple interactions |
ISO |
2 |
212,902,953 |
212,939,222 |
RGD:6480464 |
CTD |
| G |
Slc35b3 |
solute carrier family 35, member B3 |
|
multiple interactions |
ISO |
17 |
31,910,886 |
31,938,409 |
RGD:6480464 |
CTD |
| G |
Slc35d1 |
solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
|
multiple interactions |
ISO |
5 |
124,107,948 |
124,154,018 |
RGD:6480464 |
CTD |
| G |
Slc35d3 |
solute carrier family 35, member D3 |
|
multiple interactions |
ISO |
1 |
15,086,254 |
15,089,726 |
RGD:6480464 |
CTD |
| G |
Slc35e1 |
solute carrier family 35, member E1 |
|
multiple interactions |
ISO |
16 |
17,769,201 |
17,781,444 |
RGD:6480464 |
CTD |
| G |
Slc35e4 |
solute carrier family 35, member E4 |
|
multiple interactions |
ISO |
14 |
84,569,021 |
84,575,885 |
RGD:6480464 |
CTD |
| G |
Slc35f1 |
solute carrier family 35, member F1 |
|
multiple interactions |
ISO |
20 |
31,621,873 |
31,770,094 |
RGD:6480464 |
CTD |
| G |
Slc37a2 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 2 |
|
multiple interactions |
ISO |
8 |
38,484,390 |
38,506,032 |
RGD:6480464 |
CTD |
| G |
Slc38a1 |
solute carrier family 38, member 1 |
|
multiple interactions |
ISO |
7 |
135,252,257 |
135,316,256 |
RGD:6480464 |
CTD |
| G |
Slc3a1 |
solute carrier family 3, member 1 |
|
increases uptake |
ISO |
6 |
8,385,186 |
8,419,465 |
RGD:6480464 |
CTD |
| G |
Slc6a19 |
solute carrier family 6 (neutral amino acid transporter), member 19 |
|
increases uptake |
ISO |
1 |
30,393,331 |
30,412,094 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
multiple interactions |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Snrpg |
small nuclear ribonucleoprotein polypeptide G |
|
multiple interactions |
ISO |
4 |
120,549,595 |
120,557,144 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
multiple interactions |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Spag9 |
sperm associated antigen 9 |
|
multiple interactions |
ISO |
10 |
82,649,289 |
82,762,795 |
RGD:6480464 |
CTD |
| G |
Spag9 |
sperm associated antigen 9 |
|
multiple interactions |
ISO |
10 |
82,649,289 |
82,762,795 |
RGD:6480464 |
CTD |
| G |
Sptbn1 |
spectrin, beta, non-erythrocytic 1 |
|
multiple interactions |
ISO |
14 |
111,076,741 |
111,246,286 |
RGD:6480464 |
CTD |
| G |
Sptbn2 |
spectrin, beta, non-erythrocytic 2 |
|
multiple interactions |
ISO |
1 |
207,318,258 |
207,358,896 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
multiple interactions |
ISO |
7 |
120,522,511 |
120,580,212 |
RGD:6480464 |
CTD |
| G |
Srm |
spermidine synthase |
|
multiple interactions |
ISO |
5 |
165,672,516 |
165,675,673 |
RGD:6480464 |
CTD |
| G |
Ssr4 |
signal sequence receptor, delta |
|
multiple interactions |
ISO |
X |
159,710,430 |
159,714,302 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
EXP |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
decreases expression |
EXP |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tmprss2 |
transmembrane protease, serine 2 |
|
multiple interactions |
ISO |
11 |
37,577,051 |
37,617,258 |
RGD:6480464 |
CTD |
| G |
Tmsb4x |
thymosin beta 4, X-linked |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tmtc2 |
transmembrane and tetratricopeptide repeat containing 2 |
|
multiple interactions |
ISO |
7 |
43,667,983 |
44,133,854 |
RGD:6480464 |
CTD |
| G |
Tmub1 |
transmembrane and ubiquitin-like domain containing 1 |
|
multiple interactions |
ISO |
4 |
6,093,852 |
6,096,418 |
RGD:6480464 |
CTD |
| G |
Tmx4 |
thioredoxin-related transmembrane protein 4 |
|
multiple interactions |
ISO |
3 |
122,591,543 |
122,634,935 |
RGD:6480464 |
CTD |
| G |
Tnc |
tenascin C |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
multiple interactions |
ISO |
10 |
12,940,334 |
12,942,343 |
RGD:6480464 |
CTD |
| G |
Tnfrsf21 |
tumor necrosis factor receptor superfamily, member 21 |
|
multiple interactions |
ISO |
9 |
13,587,961 |
13,666,380 |
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
multiple interactions |
ISO |
5 |
169,344,695 |
169,348,961 |
RGD:6480464 |
CTD |
| G |
Tnfrsf26 |
tumor necrosis factor receptor superfamily, member 26 |
|
multiple interactions |
ISO |
1 |
203,984,072 |
204,004,029 |
RGD:6480464 |
CTD |
| G |
Tnfsf13 |
tumor necrosis factor (ligand) superfamily, member 13 |
|
multiple interactions |
ISO |
10 |
56,499,945 |
56,502,928 |
RGD:6480464 |
CTD |
| G |
Tnip1 |
TNFAIP3 interacting protein 1 |
|
multiple interactions |
ISO |
10 |
40,319,735 |
40,366,764 |
RGD:6480464 |
CTD |
| G |
Tnip2 |
TNFAIP3 interacting protein 2 |
|
multiple interactions |
ISO |
14 |
81,870,935 |
81,888,169 |
RGD:6480464 |
CTD |
| G |
Tnk1 |
tyrosine kinase, non-receptor, 1 |
|
multiple interactions |
ISO |
10 |
56,692,319 |
56,698,602 |
RGD:6480464 |
CTD |
| G |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
|
multiple interactions |
ISO |
11 |
69,927,509 |
69,966,854 |
RGD:6480464 |
CTD |
| G |
Tnks1bp1 |
tankyrase 1 binding protein 1 |
|
multiple interactions |
ISO |
3 |
68,286,407 |
68,308,256 |
RGD:6480464 |
CTD |
| G |
Tnnc1 |
troponin C type 1 (slow) |
|
multiple interactions |
ISO |
16 |
6,639,357 |
6,642,331 |
RGD:6480464 |
CTD |
| G |
Top1 |
topoisomerase (DNA) I |
|
multiple interactions |
ISO |
3 |
151,428,931 |
151,512,884 |
RGD:6480464 |
CTD |
| G |
Tpd52l1 |
tumor protein D52-like 1 |
|
multiple interactions |
ISO |
1 |
26,788,964 |
26,951,930 |
RGD:6480464 |
CTD |
| G |
Tpm4 |
tropomyosin 4 |
|
multiple interactions |
ISO |
16 |
18,108,914 |
18,122,956 |
RGD:6480464 |
CTD |
| G |
Trim6 |
tripartite motif containing 6 |
|
multiple interactions |
ISO |
1 |
162,059,220 |
162,094,672 |
RGD:6480464 |
CTD |
| G |
Trim6 |
tripartite motif containing 6 |
|
multiple interactions |
ISO |
1 |
162,059,220 |
162,094,672 |
RGD:6480464 |
CTD |
| G |
Ttc21a |
tetratricopeptide repeat domain 21A |
|
multiple interactions |
ISO |
8 |
124,895,329 |
124,929,673 |
RGD:6480464 |
CTD |
| G |
Ttc21a |
tetratricopeptide repeat domain 21A |
|
multiple interactions |
ISO |
8 |
124,895,329 |
124,929,673 |
RGD:6480464 |
CTD |
| G |
Ttc26 |
tetratricopeptide repeat domain 26 |
|
multiple interactions |
ISO |
4 |
65,922,943 |
65,981,026 |
RGD:6480464 |
CTD |
| G |
Ttc34 |
tetratricopeptide repeat domain 34 |
|
multiple interactions |
ISO |
5 |
171,658,968 |
171,668,759 |
RGD:6480464 |
CTD |
| G |
Ttk |
Ttk protein kinase |
|
multiple interactions |
ISO |
8 |
88,906,665 |
88,944,613 |
RGD:6480464 |
CTD |
| G |
Tuba4a |
tubulin, alpha 4A |
|
multiple interactions |
ISO |
9 |
74,496,508 |
74,500,192 |
RGD:6480464 |
CTD |
| G |
Twf1 |
twinfilin actin-binding protein 1 |
|
multiple interactions |
ISO |
7 |
133,089,255 |
133,101,150 |
RGD:6480464 |
CTD |
| G |
Txnl1 |
thioredoxin-like 1 |
|
multiple interactions |
ISO |
18 |
59,823,127 |
59,849,853 |
RGD:6480464 |
CTD |
| G |
Txnrd3 |
thioredoxin reductase 3 |
|
multiple interactions |
ISO |
4 |
123,730,278 |
123,771,572 |
RGD:6480464 |
CTD |
| G |
Tyrobp |
Tyro protein tyrosine kinase binding protein |
|
multiple interactions |
ISO |
1 |
85,365,371 |
85,369,224 |
RGD:6480464 |
CTD |
| G |
Uap1l1 |
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
|
multiple interactions |
ISO |
3 |
3,526,396 |
3,531,669 |
RGD:6480464 |
CTD |
| G |
Ubd |
ubiquitin D |
|
multiple interactions |
ISO |
20 |
1,475,944 |
1,477,895 |
RGD:6480464 |
CTD |
| G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
|
multiple interactions |
ISO |
4 |
57,121,159 |
57,216,956 |
RGD:6480464 |
CTD |
| G |
Uhrf1bp1 |
UHRF1 binding protein 1 |
|
multiple interactions |
ISO |
20 |
6,067,567 |
6,108,468 |
RGD:6480464 |
CTD |
| G |
Unc13a |
unc-13 homolog A (C. elegans) |
|
multiple interactions |
ISO |
16 |
18,827,405 |
18,872,461 |
RGD:6480464 |
CTD |
| G |
Unc13b |
unc-13 homolog B (C. elegans) |
|
multiple interactions |
ISO |
5 |
59,551,928 |
59,768,901 |
RGD:6480464 |
CTD |
| G |
Unc5b |
unc-5 homolog B (C. elegans) |
|
multiple interactions |
ISO |
20 |
28,095,243 |
28,162,204 |
RGD:6480464 |
CTD |
| G |
Usf2 |
upstream transcription factor 2, c-fos interacting |
|
multiple interactions |
ISO |
1 |
85,981,897 |
85,993,346 |
RGD:6480464 |
CTD |
| G |
Usp21 |
ubiquitin specific peptidase 21 |
|
multiple interactions |
ISO |
13 |
87,175,527 |
87,181,024 |
RGD:6480464 |
CTD |
| G |
Usp43 |
ubiquitin specific peptidase 43 |
|
multiple interactions |
ISO |
10 |
54,591,669 |
54,653,842 |
RGD:6480464 |
CTD |
| G |
Usp8 |
ubiquitin specific peptidase 8 |
|
multiple interactions |
ISO |
3 |
114,237,065 |
114,284,543 |
RGD:6480464 |
CTD |
| G |
Uspl1 |
ubiquitin specific peptidase like 1 |
|
multiple interactions |
ISO |
12 |
6,318,581 |
6,345,858 |
RGD:6480464 |
CTD |
| G |
Utp15 |
UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
2 |
28,837,115 |
28,853,532 |
RGD:6480464 |
CTD |
| G |
Uts2b |
urotensin 2B |
|
multiple interactions |
ISO |
11 |
75,389,855 |
75,424,944 |
RGD:6480464 |
CTD |
| G |
Vamp1 |
vesicle-associated membrane protein 1 |
|
multiple interactions |
ISO |
4 |
161,333,661 |
161,340,447 |
RGD:6480464 |
CTD |
| G |
Vezf1 |
vascular endothelial zinc finger 1 |
|
multiple interactions |
ISO |
10 |
76,364,360 |
76,374,956 |
RGD:6480464 |
CTD |
| G |
Vgf |
VGF nerve growth factor inducible |
|
multiple interactions |
ISO |
12 |
20,903,304 |
20,906,327 |
RGD:6480464 |
CTD |
| G |
Vps29 |
vacuolar protein sorting 29 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
12 |
35,403,351 |
35,412,395 |
RGD:6480464 |
CTD |
| G |
Vwf |
von Willebrand factor |
|
increases degradation |
ISO |
4 |
161,723,415 |
161,854,766 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Zfp90 |
zinc finger protein 90 |
|
multiple interactions |
ISO |
19 |
36,271,854 |
36,282,995 |
RGD:6480464 |
CTD |
| G |
Zfp91 |
zinc finger protein 91 |
|
multiple interactions |
ISO |
1 |
215,846,158 |
215,882,704 |
RGD:6480464 |
CTD |
| G |
Zic1 |
Zic family member 1 |
|
multiple interactions |
ISO |
8 |
96,314,692 |
96,318,130 |
RGD:6480464 |
CTD |
| G |
Zic3 |
Zic family member 3 |
|
multiple interactions |
ISO |
X |
143,128,118 |
143,139,155 |
RGD:6480464 |
CTD |
| G |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
|
multiple interactions |
ISO |
16 |
1,037,882 |
1,245,259 |
RGD:6480464 |
CTD |
| G |
Zmym6 |
zinc finger, MYM-type 6 |
|
multiple interactions |
ISO |
5 |
146,519,228 |
146,566,665 |
RGD:6480464 |
CTD |
| G |
Znrf1 |
zinc and ring finger 1, E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
19 |
41,455,386 |
41,537,955 |
RGD:6480464 |
CTD |
| G |
Zpbp |
zona pellucida binding protein |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Zscan12 |
zinc finger and SCAN domain containing 12 |
|
multiple interactions |
ISO |
17 |
50,892,885 |
50,894,616 |
RGD:6480464 |
CTD |
| G |
Zswim4 |
zinc finger, SWIM-type containing 4 |
|
multiple interactions |
ISO |
19 |
25,611,610 |
25,636,717 |
RGD:6480464 |
CTD |
| G |
Zswim5 |
zinc finger, SWIM-type containing 5 |
|
multiple interactions |
ISO |
5 |
137,177,583 |
137,293,556 |
RGD:6480464 |
CTD |
Term paths to the root
| Path 1 |
CHEBI ontology |
492574 |
 |
chemical entity |
492574 |
 |
atom |
491537 |
 |
nonmetal atom |
450591 |
 |
carbon atom |
407233 |
 |
organic molecular entity |
407226 |
 |
lipid |
84867 |
 |
fatty acid |
25073 |
 |
short-chain fatty acid |
17543 |
 |
butyric acid |
4097 |
 |
| (2S)-2-[(\{4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl\}carbonyl)amino]-4-(2H-tetrazol-5-yl)butanoic acid |
0 |
 |
| (2S)-3-methyl-2-((2R,3S)-3-[(methylsulfonyl)amino]-1-\{[2-(pyrrolidin-1-ylmethyl)-1,3-oxazol-4-yl]carbonyl\}pyrrolidin-2-yl)butanoic acid |
0 |
 |
| (2S,3R)-2-[(3S,6R)-3-amino-6-hydroxy-2-oxopiperidinyl]-3-hydroxybutanoic acid |
0 |
 |
| (R)-2-hydroxy-4-(hydroxymethylphosphinyl)butyric acid |
0 |
 |
| (R)-3-[(R)-3-hydroxybutanoyloxy]butanoic acid |
0 |
 |
| (R)-3-hydroxy-2-oxo-4-phosphonooxybutanoic acid |
0 |
 |
| (S)-2-acetyl-2-hydroxybutanoic acid |
0 |
 |
| 2,3-dihydroxy-3-methylbutanoic acid + |
0 |
 |
| 2,4-diaminobutyric acid + |
0 |
 |
| 2-(hydroxymethyl)-4-oxobutanoic acid |
0 |
 |
| 2-acetyllactic acid + |
0 |
 |
| 2-amino-2-methylbutanoic acid |
0 |
 |
| 2-amino-3-oxobutanoic acid + |
0 |
 |
| 2-hydroxybutyric acid + |
0 |
 |
| 2-methylacetoacetic acid |
0 |
 |
| 2-oxobutanoic acid |
1 |
 |
| 3-(indol-3-yl)-2-oxobutyric acid + |
0 |
 |
| 3-aminobutanoic acid + |
0 |
 |
| 3-hydroxy-2-methylbutanoic acid + |
0 |
 |
| 3-hydroxybutyric acid + |
8 |
 |
| 3-hydroxyisovaleric acid + |
0 |
 |
| 3-methyl-2-oxobutanoic acid |
2 |
 |
| 4-(2-amino-3-hydroxyphenyl)-2,4-dioxobutanoic acid |
0 |
 |
| 4-(2-amino-5-hydroxyphenyl)-2,4-dioxobutanoic acid |
0 |
 |
| 4-(2-aminophenyl)-2,4-dioxobutanoic acid |
0 |
 |
| 4-(2-thienyl)butyric acid |
0 |
 |
| 4-(5-ethyl-2-thienyl)-4-oxobutyric acid |
0 |
 |
| 4-(hydroxymethylphosphinyl)-2-oxobutyric acid |
0 |
 |
| 4-(methylamino)butyric acid |
0 |
 |
| 4-[3-(3-nitrophenyl)-1,2,4-oxadiazol-5-yl]butanoic acid |
0 |
 |
| 4-[4-(2,5-dioxopyrrolidin-1-yl)phenylamino]-4-hydroxybutyric acid |
0 |
 |
| 4-[4-(3,5-dioxohexyl)phenylcarbamoyl]butyric acid |
0 |
 |
| 4-acetamidobutanoic acid |
0 |
 |
| 4-guanidinobutanoic acid |
0 |
 |
| 4-hydroxybutyric acid + |
3 |
 |
| 4-methylthio-2-oxobutanoic acid + |
2 |
 |
| 4-oxo-4-(2-thienyl)butyric acid |
0 |
 |
| 4-oxo-4-phenylbutyric acid |
0 |
 |
| 4-phenylbutyric acid |
125 |
 |
| L-2,4-diaminobutyric acid + |
0 |
 |
| L-2-amino-4-(hydroxymethylphosphinoyl)butanoic acid |
0 |
 |
| acetoacetic acid + |
0 |
 |
| alpha-amino-gamma-cyanobutanoic acid |
0 |
 |
| alpha-aminobutyric acid + |
0 |
 |
| butanoate ester + |
164 |
 |
| butyryl group |
0 |
 |
| butyryl-CoA + |
0 |
 |
| dimethylbutyric acid + |
0 |
 |
| discadenine |
0 |
 |
| gamma-amino-beta-hydroxybutyric acid + |
0 |
 |
| gamma-amino-gamma-cyanobutanoic acid + |
0 |
 |
| gamma-aminobutyric acid + |
193 |
 |
| heptafluorobutyric anhydride |
0 |
 |
| indole-3-butyric acid |
4 |
 |
| methionine + |
3239 |
 |
| methylbutyric acid + |
197 |
 |
| perfluorobutyric acid |
22 |
 | |
|